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Abstract 
 
Background 
The discharge summary is a critically important form of communication when a patient is 
discharged from hospital. It has been shown in numerous studies that discharge 
summaries often lack sufficient information, with deficiencies in completeness and 
accuracy, and may not be received by the GP surgery before the patient’s first post-
discharge contact. Poor quality medicines-related information can result in unintentional 
changes to the patient’s medication after discharge. Increasingly discharge summaries are 
being prepared and transmitted electronically; but research into the quality of medicines-
related information in the electronic discharge summary was scant and not UK based. 
 
Aims 
To list and describe the content of medicines-related information in the electronic 
discharge summary, and evaluate the quality of information for completeness, accuracy 
and timeliness. To evaluate the quality of information about medication changes in the 
electronic discharge summary for completeness and accuracy. 
 
Method 
Prospective content analysis of medicines-related information in a sample of the 
electronic discharge summaries generated over a two month period at a 400 bed general 
hospital. A stratified random sample of 10% of the electronic discharge summaries were 
further analysed to evaluate the quality of information about medication changes; by 
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identifying if medication changes had occurred, and whether they were listed and the 
reasons for changes stated completely and accurately. 
 
Results 
The majority of electronic discharge summaries were prepared by junior doctors, and in a 
timely manner in 97% of the sample of 1306 summaries. They contained medicines-
related information categorised as allergies, discharge medications, and medication notes. 
Allergies data and discharge medication lists were complete and accurate in 96% and 
89% of the summaries respectively; medication notes were written in 73%, most 
frequently about medication changes. Medication changes occurred, between admission 
and discharge, in 96% of cases; new medications were started (87%) more frequently 
than admission medications were changed (59%). Information about these medication 
changes were present in 69% of summaries, and were complete and accurate in 22% and 
16% respectively. Complete and accurate information about all medication changes were 
shown in only 13% of summaries. 
 
Conclusion 
Electronic discharge summaries make an important contribution to patient safety in 
generating legible and timely information about allergies and discharge medications; but 
do not completely eliminate the risk of inaccurate or incomplete information. 
Documentation of information about medication changes in the electronic discharge 
summary was frequently incomplete or inaccurate. There was a gap between the need for, 
and provision of, information about medication changes in the discharge summary. 
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Section 1 Introduction 
 
There are many instances of failure in continuity of care at the interface of primary and 
secondary care, which pose a patient safety risk. These problems, which are particularly 
associated with admission to and discharge from hospital, also occur when patients are 
transferred between wards and care teams. As many as one fifth of patients discharged 
from hospital may experience an adverse event within one month of discharge (Forster, 
Murff, Peterson, Gandhi, & Bates, 2003), and a proportion of these may be readmitted 
(Moore, Wisnivesky, Williams, & McGinn, 2003). Many of these adverse events relate to 
medication and are preventable (Forster et al., 2004). 
 
Safe transfer of care often centres upon effective communication that is timely, accurate 
and complete. Research studies investigating communication at transfer from one care 
setting to another, mostly admission to and discharge from hospital, span nearly thirty 
years (Kripalani et al., 2007). The discharge summary is often the only form of 
communication when a patient is discharged from hospital to home. However, it has been 
demonstrated in numerous studies that discharge summaries often lack sufficient 
information (Foster, Paterson, & Fairfield, 2002), and may not be received by the GP 
surgery before the patient has their first post-discharge visit (van Walraven, Seth, & 
Laupacis, 2002a). As a consequence, unintentional changes to medication occur in a high 
proportion of patients after discharge. This can include medicines being incorrectly 
stopped or restarted, changes to dosage or directions, and inadvertent duplication of 
medication which can have a negative impact on patient care (Department of Health 
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[DOH], 2003). Managing medicines when a patient is transferred from one setting to 
another is central to safe, high-quality care. 
 
Effective communication at discharge has been demonstrated to reduce unplanned GP 
visits and re-admissions, and to prevent medication errors and adverse events (Kripalani 
et al, 2007). Research studies have identified and described what constitutes a high 
quality discharge summary (van Walraven & Rokosh, 1999a), and guidelines have been 
published describing the minimum dataset of information that should be within the 
discharge summary (Scottish Intercollegiate Guidelines Network [SIGN], 2003). There is 
however repeated evidence that practice continues to fall short of the recommended 
standards (Care Quality Commission [CQC], 2009). Information technology may offer an 
integrated solution to ensuring the safe transfer of care, by facilitating the writing of the 
discharge summary and prescription, and the timely dissemination of discharge 
information. Research into the quality of information, and in particular medicines-related 
information, in the electronic discharge summary is scant and mostly conducted in the 
Unites States or Australia (O’Leary et al., 2009; Callen, Alderton, & McIntosh, 2008). 
 
This introduction will provide background to the problem of communication at the 
interface between secondary and primary care, and in particular the transfer of medicines-
related information. It will explore current methods of communication at the interface and 
the benefits of an electronic discharge summary. 
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1.1 Patient safety 
 
Patient safety within the healthcare setting has been the subject of academic research in 
the USA (Brennan et al., 1991), Canada (Baker et al., 2004) and Australia (Wilson et al., 
1995) as well as the UK (Vincent, Neale, & Woloshynowych, 2001). Patient safety 
encompasses a range of errors and system failures associated with the delivery of patient 
care. This can include situations such as mistakes and delays in diagnosis, medication and 
treatment errors, problems with equipment, infections acquired in hospitals and accidents 
such as slips and falls. 
 
International retrospective reviews of medical records in acute hospitals have 
demonstrated variable rates of adverse events, ranging from 3.7% to 16.6%; with around 
half being judged to be preventable (Brennan et al., 1991; Baker et al., 2004; Vincent et 
al., 2001; Wilson et al., 1995). A retrospective study of patient records in two English 
hospitals found 10.8% of patients experienced an adverse event; of which 48% were 
judged to have been preventable (Vincent et al., 2001).  
 
Given the unacceptably high rate of adverse events in many developed countries, 
improving patient safety is a key priority for healthcare organisations.  
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1.1.1 UK patient safety agenda 
 
Improving patient safety is a significant challenge for the NHS, as it is for many 
healthcare services around the world. The introduction of clinical governance as a key 
component of the government’s modernisation programme put quality at the top of the 
NHS agenda, and provided a new model for NHS organisations to minimise the risk of 
adverse events in patient care (DOH, 1998). 
 
In 2000, the UK was one of the first countries to give priority to improving patient safety 
with the publication of ‘An Organisation with a Memory’ (DOH, 2000a); which 
coincided with the US Institute of Medicine’s report ‘To Err is Human’ (US Institute of 
Medicine, 2000). In the process, patient safety became a key part of the NHS Plan and the 
NHS quality agenda (DOH, 2000b). Since then a number of reports and reviews of 
patient safety have been published in the UK, and the National Patient Safety Agency 
(NPSA) was established in 2001. Organisations that have a significant role to play in 
improving patient safety at national level include: the NPSA, the Care Quality 
Commission (CQC) and Connecting for Health. 
 
 
1.1.1.1 An organisation with a memory 
 
In 2000, the Department of Health (DOH) publication ‘An Organisation with a Memory’ 
set out to review what was known about the scale and nature of serious failures in NHS 
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healthcare, the extent to which the NHS had the capacity to learn from untoward 
incidents and service failures and avoid them in the future, to draw conclusions and make 
recommendations (DOH, 2000a). 
 
The report confirmed that, where errors and failures occurred, there had been little 
systematic learning, and patients suffered unnecessary and avoidable harm. It identified 
that the key barriers to reducing the number of patient safety incidents were an 
organisational culture that inhibited reporting and the lack of a cohesive national system 
for identifying and sharing lessons learnt. The overall policy objective of the report was 
to provide a national system for recording and learning from adverse events and near 
misses, so that the NHS could minimise such incidents in the future. A new independent 
body, seen to be neutral by healthcare staff, would be established to run the system 
(DOH, 2000a). 
 
 
1.1.1.2 Building a safer NHS for patients 
 
 In 2001, the DOH published ‘Building a Safer NHS for Patients’ in response to ‘An 
Organisation with a Memory’ and commitments in the NHS plan. It set out in more detail 
the government’s plans for improving patient safety and described how to implement the 
key recommendations, detailing plans and a timetable for promoting patient safety (DOH, 
2001). 
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Specific risk areas were targeted for action, including: by 2005, to reduce by 40% the 
number of serious errors in the use of prescribed medicines. The report identified that 
various forms of medication error comprise a large category of events posing a threat to 
patient safety, and that patients can be seriously harmed as a result (DOH, 2001). 
 
The report highlighted that a reporting culture, building local capability and sustaining 
change through education, learning and performance assessment at local and national 
level, were key to fully embedding patient safety within the NHS. Central to this was the 
new mandatory, national reporting scheme for adverse events and near-misses. The report 
announced the establishment of the NPSA, to implement, operate and oversee all aspects 
of the new national system for learning from adverse events and near misses in all sectors 
of the NHS (DOH, 2001). 
 
 
1.1.1.3 National Patient Safety Agency 
 
The NPSA is an independent body of the DOH, which was established in 2001, with the 
responsibility of improving the safety and quality of patient care through promoting a 
culture of reporting and learning from patient safety incidents, and by introducing a 
national reporting and learning system to support this function (National Patient Safety 
Agency [NPSA], 2008).  
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The NPSA consists of three divisions: the National Reporting and Learning Service 
(NRLS); the National Clinical Assessment Service; and National Research Ethics 
Service. The NRLS is the NPSA’s primary mechanism for collecting information on 
patient safety incidents and near misses from all NHS organisations in England and 
Wales. Incidents, reported anonymously to the NRLS, are analysed to identify risks to 
patients and opportunities to improve patient safety (National Reporting and Learning 
Service [NRLS], 2009). Learning is disseminated through patient safety alerts, ‘seven 
steps to patient safety’ series of guides, data reports and Patient Safety Observatory 
(PSO) guides. 
 
The NRLS and the PSO published its first report in July 2005, which stated that patient 
accidents, incidents associated with treatment or procedure and medication incidents were 
the most common types of incidents reported to the NRLS (NPSA, 2005). 
 
 
1.1.1.4 A safer place for patients 
 
The National Audit Office (NAO) published ‘A Safer Place for Patients’ in November 
2005. The report followed a review by the NAO of the implementation of the 
government’s policy on patient safety. It examined whether the NHS had been successful 
in improving the patient safety culture, encouraging reporting and learning from patient 
safety incidents (National Audit Office [NAO], 2005). 
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It concluded that at a local level, there had been progress with improvements in reporting 
and a more open and fair reporting culture. However, at the national level, there had been 
delays in establishing an effective national reporting system and there was a need to 
improve evaluation and sharing of lessons and solutions by all organisations with a stake 
in patient safety (NAO, 2005). 
 
 
1.1.1.5 Safety first 
 
In December 2006, the DOH published a report, ‘Safety First’, which reviewed the 
organisational arrangements in place to support patient safety. This patient safety review, 
commissioned by the Chief Medical Officer, aimed to address issues raised by the NAO 
in its report ‘A Safer Place for Patients’, as well as look at the NHS approach to patient 
safety more widely (DOH, 2006).  
 
The report highlighted the need to build on the progress already achieved in embedding 
patient safety in the NHS, and simplify the reporting of adverse effects to make it easier 
for clinical staff to report on a confidential basis. It concluded that more could be done to 
make patient safety a priority at a local level and to maximise impact (DOH, 2006).  
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1.1.2 Medication safety 
 
Medication safety is an important aspect of patient safety. The prescribing of medicine is 
probably the most common intervention made by healthcare professionals, and taking any 
medicine is an inherently risky business. Most medicines are used safely and correctly, 
but even so, there is the chance of an adverse drug reaction, side effect or drug interaction 
occurring. When medicines are used incorrectly, the risk of harm to patients may be 
increased (Royal Pharmaceutical Society of Great Britain [RPSGB], 2006). Medication 
errors occur when human and system factors interact with the complex process of 
prescribing, dispensing and administering medicines to produce an unintended and 
potentially harmful outcome. Medication errors are one of the most common types of 
adverse event, and the single most preventable cause of patient harm (Audit Commission, 
2001). 
 
There is evidence from the international literature that medication errors occur in all 
healthcare systems. Adverse drug events have been reported to account for between 10 
and 26% of all adverse events. The Harvard Medical Practice study in the USA found 
that medicine complications were the most common type of adverse event (19%), 
affecting 1% of admissions (Leape et al., 1991). The Quality in Australian Health Care 
study, which used the same methodology, found that 10% of adverse events were 
medicine related, equivalent to 1.7% of admissions (Wilson et al., 1995). A later review 
of incidents collected in Australian hospitals found that 26% were medicine related 
(Runciman, Roughead, Semple, & Adams, 2003). A US study specifically assessing the 
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incidence and preventability of adverse drug events found that they occurred in 6.5% of 
admissions, and that 28% of these were preventable (Bates et al., 1995). 
 
Improving medication safety is a priority for healthcare services in Europe, North 
America, Australia and many other countries. In the UK, managing medicines safely and 
effectively is central to the NHS patient safety strategy. The need for this was highlighted 
in a number of reports published by the NPSA, DOH, and CQC. By identifying areas of 
particular risk, NHS organisations and healthcare professionals can take action to 
significantly improve the safety of patients receiving and taking medicines. 
 
 
1.1.2.1 Building a safer NHS for patients: improving medication safety 
 
In January 2004, the Chief Pharmaceutical Officer published ‘Building a Safer NHS for 
Patients: improving medication safety’, which looked specifically at medication safety 
(DOH, 2004a). This report explored the frequency, nature and causes of medication 
errors, highlighted drugs, patient groups and clinical settings that carry particular risks, 
and identified models of good practice to reduce risks. The report also highlighted the 
risk of medication errors arising at ‘handover points’ within the healthcare system and 
stressed the critical importance of communication when patients are moving from one 
care setting to another (DOH, 2004a). 
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1.1.2.2 Safety in doses: medication safety incidents in the NHS 
 
In 2007, the NPSA published ‘Safety in Doses: medication safety incidents in the NHS’, 
which gave detailed analysis of the medication incidents reported by NHS staff in 
England and Wales between January 2005 and June 2006 (NPSA, 2007a). Through 
analysis of almost 60,000 medication incident reports received by the NRLS, it identified 
the rate and impact of medication incidents, described the areas of risk to patient safety 
and recommended priority actions for healthcare organisations and staff to improve 
medication safety (NPSA, 2007a). It was recognised that there was significant under-
reporting of incidents and potential for bias in the types of incident that were reported 
(DOH, 2006), so the NRLS may not capture all patient safety incidents.  
 
NHS staff reported 59,802 medication safety incidents to the NRLS (8.3% of all reported 
incidents), which was the second most common type of patient safety incident reported 
after patient accidents (38.8%). The vast majority of the medication safety incidents 
reported to the NRLS were from hospitals (78%) and 83% resulted in no harm to patients. 
The three most common types of medication errors reported to the NPSA, which 
accounted for over half (57.3%) of all medication incidents, were: wrong dose, strength 
or frequency; omitted medicine; and wrong medicine. Prescribing omissions may occur 
when the medication history of a patient is either unavailable or incomplete, resulting in 
essential medication being left off the patient’s prescription. This is more likely to occur 
at transfer of care, when patients are admitted to or discharged from hospital. It was also 
found that certain patient groups may be more vulnerable to medication errors; these were 
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patients with known allergies to certain medicines, children, patients moving across care 
settings and patients cared for outside of normal processes (NPSA, 2007a). 
 
Analysis of medication incidents identified that a recurrent risk was when patients were 
transferred between care teams and settings, such as when patients were admitted to or 
discharged from hospital. In particular, the report highlighted that poor communication at 
the interface between secondary and primary care often resulted in patient safety 
incidents. For example, incomplete or incorrect medication history on admission to 
hospital, incorrect or incomplete discharge medicines, failure to communicate changes in 
medication regime, or lack of monitoring or follow-up on discharge from hospital can all 
result in patient safety incidents (NPSA, 2007a). 
  
 
1.1.2.3 Safety in doses: improving the use of medicines in the NHS 
 
Two reports titled ‘Safety in Doses: improving the use of medicines in the NHS’ were 
published by the NPSA in 2007 (NPSA, 2007b) and 2009 (NPSA, 2009). The 2007 
report highlighted key findings from the earlier report ‘Safety in Doses: medication safety 
incidents in the NHS’. Analysis of incident reports informed the development of the 
NPSA’s safe medication practice work programme for 2007-08, and an overview of this 
programme of five patient safety alerts was set out in this report (NPSA, 2007b). 
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The 2009 report provided an overview of in-depth analysis of medication incidents from 
England and Wales reported to the NRLS between 1 January 2007 and 31 December 
2007 (NPSA, 2009). There was a significant increase in reporting of medication incidents 
to the NRLS. NHS staff reported 72,482 medication safety incidents to the NRLS (9% of 
all reported incidents), which was the third most common type of patient safety incident 
reported after patient accidents (38.8%) and treatment or procedure incidents (9%). The 
vast majority of the medication safety incidents reported to the NRLS were from 
hospitals (76%) and 80% resulted in no harm to patients (NPSA, 2009). 
 
The report highlighted incidents which occurred due to a breakdown in communication 
between healthcare professionals and across healthcare sectors. When people transfer 
from one sector to another, for example on admission to hospital, there was a greater risk 
of medication error occurring. The most common interface where incidents were reported 
was between secondary and primary care when patients were discharged from hospital or 
following outpatient appointments. The report recommended: a review of communication 
of key medicines-related information at the point of transfer of care to identify high-risk 
areas requiring action; review of processes for the accurate and timely transfer of 
medicines-related information across all interfaces, but in particular in conjunction with 
the acute sector; and that organisations should review the need to expand reconciliation 
beyond adult admission to hospital (NPSA, 2009). 
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1.1.2.4 Managing patients’ medicines after discharge from hospital 
 
In October 2009, the CQC published a report ‘Managing patients’ medicines after 
discharge from hospital’, which specifically looked at what organisations were doing to 
ensure the safety of patients who had been discharged from hospital with a change of 
medication (CQC, 2009). The findings were based on a national study that visited 12 
primary care trusts and surveyed 280 of their GP practices. It found that there were good 
systems in place to ensure the safety of repeat prescribing, and to ensure that reviews of 
medication for high-risk patients took place after their discharge from hospital. However, 
acute trusts needed to improve the quality of information sent to GPs in discharge 
summaries, and PCTs needed to ensure that better information was sent to hospitals on 
admission and that there were safe processes in place for critically reviewing medication 
changes and updating patients’ records after they were discharged (CQC, 2009). These 
findings were also highlighted in a subsequent CQC report published in 2010 (CQC, 
2010). 
 
 
1.2 Adverse events after discharge from hospital 
 
It is acknowledged nationally and internationally that patients face a significant risk of 
adverse events during the transition from the hospital to the home (Forster et al., 2003, 
Forster et al., 2004). Adverse events can happen during any transfer from one care setting 
to another: from home to hospital; from one hospital ward to another; from one hospital 
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to another; from hospital to intermediate care, care home or hospice; or from hospital to 
home. Patients are particularly vulnerable on discharge from hospital, when there are 
potentially more factors which can lead to problems; these are discussed below. 
 
 
1.2.1 Risk factors associated with discharge from hospital 
 
Processes at the patient, doctor and organisational levels have been identified as potential 
risk factors that can facilitate or impede safe patient transitions (Coleman, 2003). There 
are reasons for this increase in risk; healthcare is a complex, fragmented, and 
discontinuous system that provides opportunities for systemic failure that can adversely 
affect patient safety (Berwick & Leape, 1999).  
 
Cook et al described how complex systems involve many gaps between people, stages 
and processes. Gaps, which are discontinuities in care, may be problematic and need to be 
recognised and bridged by healthcare professionals to prevent risk of adverse events and 
harm to patients. When a patient is discharged from hospital a gap in care may appear as 
loss of information or momentum or an interruption in the delivery of care (Cook, 
Render, & Woods, 2000). 
 
Errors often occur during the transitional phase of any system, and one strategy for 
reducing errors associated with transitions is seamless care; defined as the smooth and 
safe transition of a patient from the hospital to home setting. Coleman described the 
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multiple points during a transition at which care processes can break down, including: 
preparation of the patient and caregiver; the communication of vital elements of the care 
plan; the reconciliation of the medication regimen that was prescribed before the initial 
transition with the current regimen; the transportation of the patient; the completion of 
follow-up care with a practitioner, diagnostic imaging or laboratory testing; and the 
availability of advance care directives across settings (Coleman, 2003). Well executed 
transitions were not without risk for adverse outcomes, but poor transitions could be 
associated with an increased risk of adverse effects which were potentially preventable 
(Coleman, 2003). 
 
Shorter hospitalisations may contribute to the risk of adverse effects as problems may not 
develop until well after the patient arrives home, and some patients may be discharged 
with unresolved medical issues (Moore, McGinn, & Halm, 2007). The effect of new 
drugs started in the hospital, the development of wound or other nosocomial infections, 
and the latent effect of procedures can become evident after discharge to the community. 
 
Patients may be at increased risk of adverse events after discharge because they may still 
have functional impairments (Cook et al., 2000). The elderly and people with continuous 
complex care needs are particularly vulnerable to adverse events during transitions 
between care settings (Coleman, 2003). Discharge from hospital is a time when patients 
frequently experience extreme changes in health and therapy. Communication of these 
changes between hospital doctors and GPs can be inadequate and, for these reasons, 
adverse events may be common after discharge. 
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1.2.2 Incidence and types of adverse events after discharge 
 
Two prospective cohort studies of medical and elderly patients by Canadian researchers 
found that adverse events occur after one in five medical discharges, and that these may 
contribute to readmission. The first study found that 19% of medical patients discharged 
from a teaching hospital in the USA experienced an adverse event within one month; 
many were preventable or ameliorable and the majority (66%) related to medicines, 
followed by therapeutic errors, nosocomial infections and falls (Forster et al., 2003). The 
second study found that 23% of medical and elderly patients discharged from a Canadian 
hospital had an adverse event after discharge, of which half were preventable or 
ameliorable, and the majority (72%) related to medicines (Forster et al., 2004). The most 
common deficit in the provision of discharge care was poor communication, which 
contributed to many of the preventable or ameliorable adverse events (Forster et al., 
2003). 
 
Moore et al found that almost half of patients had experienced one or more medical errors 
which they categorised as medication continuity errors, test follow-up errors or work-up 
errors (Moore et al., 2003). The most frequent type of error was medication continuity 
error. They did not find an association between medication continuity error or test follow-
up error with rehospitalisation, but found an association between work-up error and 
increased likelihood of rehospitalisation within three months. 
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A survey in the UK in 2008 by the NHS Alliance showed that 26% of GPs said that 
patient lives were being put at risk because hospitals were failing to provide essential 
information about medication or treatment when a patient was discharged (Gould, 2008). 
 
 
1.2.3 Medication errors following discharge from hospital 
 
There are many reasons why errors occur with patients’ medication, and research into this 
area has helped identify particular themes These include poor communication between 
teams or organisations when the responsibility for a patient’s care is transferred from one 
care setting to another; a lack of suitable monitoring and review of treatment; or patients 
not taking their medicines as agreed. 
 
The medicines that patients take home, when discharged from hospital, fall into the 
following broad groups: regular medicines started before the hospital admission; 
replacement regular medicines, which have undergone changes whilst in hospital; 
additional regular medicines, which have been added during the hospital stay and are to 
be continued by the GP; and short term medicines directly related to the hospital stay e.g. 
post-operative pain relief or antibiotics to treat or prevent infection (RPSGB, 2006). In 
addition the patient may have regular medicines at home that were unintentionally or 
intentionally stopped in hospital, either due to omission from the drug history or an 
adverse drug effect.  
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The common medication problems following discharge have been described as follows 
(DOH, 2003): 
- information on patients’ medicines received by the hospital may not be fully 
accurate, and the wrong medication may be continued during the hospital stay and 
on discharge; 
- patients view their hospital medication and home medication as different and may 
take both, thus taking double doses of some medicines; 
- when home, patients inappropriately revert to their pre-admission medication; 
- repeat GP computer generated prescriptions following discharge are not always 
up to date with the revised hospital medication plan; 
- the discharge summary arrives at the GP practice after the repeat prescription has 
been issued; 
- the discharge summary does not give full information, and the GP is not clear on 
the exact changes in medication that have been made during the hospital stay; 
- lack of communication between hospital and patient’s community pharmacist; and 
- disagreements on appropriate prescribing between hospital doctors and GPs 
leading to switching of patients’ medicines after discharge e.g. to cheaper or 
formulary drugs. 
 
The outcome of these medication problems may be inappropriate changes to medication 
by the GP or lack of compliance by the patient after discharge which may contribute to 
ongoing or new morbidity and lack of health gain for patients (RPSGB, 2006). To ensure 
that ongoing care is consistent with any new medication regimen that is introduced in the 
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hospital, information on medication changes should be sent to GPs when a patient is 
discharged. 
 
A study in 1992, followed-up 50 elderly patients discharged from geriatric wards. 
Patients were discharged with five days supply of medication, and written instructions, 
including a copy of their prescription, to take to their GP. Patients were visited at home 
six to 14 days after discharge, when their initial supply should have run out and a further 
supply obtained from the GP. In 90% of the patients studied there was a lack of 
continuity between the medicines at discharge and those being taken post-discharge 
(Cochrane, Mandal, Ledger-Scott, & Walker, 1992). Discrepancies included medicines 
being stopped or started, dosage or directions being changed, and those medicines which 
had originally been dispensed with specific instructions subsequently labelled ‘as 
directed’. Most of the patients had not been seen by their GP since discharge, and it was 
concluded that the majority of the changes were unintended (Cochrane, Mandal, Ledger-
Scott, & Walker, 1992) and the supply of only five days of medication contributed to the 
problem. 
 
A study in 1996, followed-up 50 general medical patients discharged with 483 prescribed 
medicines. Patients were visited at home one and six weeks post-discharge, by which 
time most had collected a new prescription. Discrepancies in post-discharge prescribing 
were classified as ‘intentional’ or ‘unintentional’ (Duggan, Bates, & Hough, 1996). 
Intentional discrepancies were identified in 35% of medicines at visit one and in 8% at 
visit two. Unintentional discrepancies were identified in 11% of medicines at visit one 
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and in 46% at visit two. Many changes that occurred to prescribed medicines after 
discharge were unintentional, and were dependent on either different labelling or supply 
systems or breakdown in communication between secondary and primary care (Duggan, 
Bates, & Hough, 1996). 
 
 
1.2.4 Hospital readmission  
 
A number of studies have found that adverse drug events contribute to admission to 
hospital, particularly in elderly patients. A study in Cambridge of the incidence and 
nature of drug-related admission to hospital identified that more than 10% of admissions 
to a medical admissions ward were drug-related; 50% were categorised as definitely 
drug-related, and 44% were classified as severe (Bhalla, Duggan, & Dhillon, 2003). A 
prospective analysis of all admissions to two hospitals in Merseyside found a prevalence 
of 6.5% related to adverse drug reactions; with it directly leading to admission in 80% of 
cases (Pirmohamed et al., 2004). The elderly are more susceptible to adverse drug 
reactions. A study of elderly patients admitted to all wards in Tayside hospitals identified 
5.3% of admissions to be definitely or probably drug-related (Cunningham, Dodd, Grant, 
McMurdo, & Richards, 1997). Another study of elderly patients admitted to five general 
medical wards, identified that 17% were admitted because of an adverse drug reaction 
(Mannesse et al., 1997). Similarly, poor compliance with medication or unintended 
changes to medication regimens after discharge can jeopardise treatment and increase the 
risk of unplanned readmission to hospital. 
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One risk, particularly associated with discharging elderly patients from hospital, is 
unplanned readmission; which was shown to be 6% within 28 days of discharge in a UK 
study (Williams & Fitton, 1988). There were seven possible principal reasons for 
readmission: relapse of initial illness; new problem developed; carer problems; 
complications of initial illness; terminal care; medication problems; and problems with 
services. There were also contributory reasons for readmission including lack of 
information from the hospital to the GP (47%), and medication problems (29%). In 59% 
of cases, readmission could have been avoided by more effective action at the time of 
discharge (Williams & Fitton, 1988). Other studies in Canada found that there were less 
readmissions if post-discharge follow-up of the patient was with the doctor who treated 
them in hospital (van Walraven, Mamdani, Fang, & Austin, 2004), or the discharge 
summary was available for the first post-hospital visit (van Walraven, Seth, Austin, & 
Laupacis, 2002b). 
 
A retrospective case-note review of elderly patients, who were readmitted within 28 days, 
identified communication gaps at hospital discharge and assessed their contribution to 
readmission. At readmission, 62% of patients had no discharge summary available, and 
incomplete discharge medication information was the dominant reason for 10% of the 
readmissions (Witherington, Pirzada, & Avery, 2008). The authors found that 
information important to safe continuity of care was often missing at discharge, accurate 
information on changes to medication was missing from two thirds of all discharge 
documents, and medication problems following discharge were common. At review, 38% 
of readmissions were considered to be medication related and 61% preventable. In 21%, 
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medication was the dominant reason for readmission, although this study could not 
establish a causal link between missing information and adverse events or readmission 
(Witherington et al., 2008). 
 
Studies have shown a strong relationship between discrepancies in discharge medication 
and readmission (Coleman, Smith, Raha, & Min, 2005). A study in the USA found that 
14.3% of older patients who experienced post-hospital medication discrepancies were 
hospitalised at 30 days compared with 6.1% of the patients who did not experience a 
discrepancy. Failure to convey accurate, complete and up-to-date information across 
interfaces in care is a major, avoidable risk to patient safety (Coleman et al., 2005). 
 
 
1.3 Improving hospital discharge 
 
The DOH first published the ‘Hospital Discharge Workbook’ in 1994 which contained 
guidance on good practice in all aspects of hospital discharge. This was superseded in 
2003 by the publication of the best practice guidance ‘Discharge from hospital: pathway, 
process and practice’ written by the Health and Social Care Joint Unit and Change Agent 
Team (DOH, 2003). This document is described in more detail below. 
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1.3.1 Discharge from hospital: pathway, process and practice 
 
This publication provided guidance and practical tools to improve local hospital 
discharge policy and practice. The workbook highlighted that the key principles 
underpinning effective discharge and transfer of care include: that discharge is a process, 
and not an isolated event, which needs to be planned for at the earliest opportunity; the 
process should be co-ordinated by a named person who has responsibility for co-
ordinating all stages of the patient journey; and it is best achieved through multi-
disciplinary and multi-agency team working to manage all aspects of the discharge 
process. Effective discharge planning is a complex process. The workbook provided 
guidance on each of the specific stages involved within the whole system approach, 
including the important role of medicines management during the patient journey in 
preparing the patient and their carers for transfer or discharge (DOH, 2003).  
 
 
1.3.2 Achieving timely simple discharge from hospital 
 
Further best practice guidance was published by the DOH in 2004, in the toolkit 
‘Achieving timely simple discharge from hospital’. Simple discharges involve patients 
discharged to their own home have simple ongoing healthcare needs which can be met 
without complex planning. It focused on the practical steps the multi-disciplinary team 
could take to improve simple discharges. It included practical advice, factsheets and case 
studies aimed at the 80% of patients classified as simple discharges (DOH, 2004b). 
 25 
1.3.3 Moving patients, moving medicines, moving safely 
 
Managing medicines effectively when a patient is discharged from hospital is central to 
ensuring safe, high-quality care and reducing avoidable readmissions, and this was 
specifically addressed in the publication ‘Moving patients, moving medicines, moving 
safely’. This guidance on discharge and transfer planning, published in 2006, was 
developed by a group of national pharmacy organisations; the Royal Pharmaceutical 
Society of Great Britain (RPSGB), Pharmaceutical Services Negotiating Committee, 
Primary Care Pharmacists’ Association, and Guild of Healthcare Pharmacists. It provided 
practical guidance in developing systems to tackle discharge and transfer problems 
between different settings and was based on experiences and evidence available. The aim 
of this guidance was to help multidisciplinary teams maximise good practice and 
minimise the risks for patients associated with their medicines, during the transfer and 
discharge process (RPSGB, 2006). 
 
This guidance highlighted that, to maximise effective discharge and minimise the risks 
relating to medicines use, the evidence suggests that the elements of a successful service 
should include (RPSGB, 2006): 
- mechanisms for effective communication in place to facilitate early discharge 
planning; 
- medicines reconciliation on admission, since a complete and accurate drug history 
is the foundation on which discharge medication is based; 
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- using patients’ own drugs and dispensing for discharge, to reduce the risk of 
duplicate or discontinued medication being taken once the patient returns home; 
- encouraging patients to self administer their medication where appropriate;  
- reviewing medication, especially where there have been changes and additions to 
medication; 
- obtaining prescriptions and medicines in good time and in sufficient quantity so 
that they are available when needed for discharge; 
- verbal counselling of patients accompanied by written discharge information, 
which increases knowledge and compliance; 
- pharmacist-written discharge prescriptions, which reduce error rates; 
- ensuring discharge medication summaries are received by the patient’s GP and 
community pharmacist before a repeat prescription is required, to reduce the risk 
of unintentional changes to medication; 
- electronic prescriptions, which make the transfer of information between the 
ward, pharmacy and GP practice easier; 
- clear practice protocols within GP surgeries, to make sure that information 
received about revised medication is updated to the patient’s medical and 
computer records; and 
- medication management services for high risk patients that ensure they are able to 
continue with their medication regimen after discharge and prevent readmission. 
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1.4 Discharge communications 
 
Effective communication between hospitals and GPs is essential for the continuity of care 
of patients being transferred from hospital care back into the community. Currently when 
a patient is discharged from hospital, the GP is completely dependent on the discharge 
summary for information about the patient. Research shows that poor information 
transfer and discontinuity are associated with lower quality of care on follow-up, as well 
as adverse clinical outcomes (Witherington et al., 2007). Conversely good 
communication contributes to continuity of care, which optimises beneficial clinical 
outcomes for patients, and minimises adverse events and risk of readmission (van 
Walraven et al., 2002b). 
 
 
1.4.1 Forms of communication between primary and secondary care 
 
Communication between secondary and primary care when a patient is discharged has 
variously been described in studies as a discharge summary, immediate discharge 
summary, immediate discharge document, interim discharge summary, initial discharge 
summary, discharge letter, discharge note, discharge referral letter, discharge report and 
final discharge report. In some cases a first and second communication will be sent to the 
GP, in the form of an initial discharge summary followed by a more detailed discharge 
report; in others the discharge summary comprises the only communication. There is 
clearly a lack of standardisation in both the nomenclature used and the process of 
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producing discharge documents. For the purposes of this report the term discharge 
summary will be used to describe the discharge document produced at the point of 
discharge.  
 
The discharge summary is one of the most common methods used by hospital doctors to 
transfer information and communicate with GPs when a patient is discharged from 
hospital (Long & Atkins, 1974). It has traditionally been via hard copy, either 
handwritten or typed, discharge summary posted to the GP and also issued to the patient 
on discharge in some cases. Increasingly electronic discharge summaries are being 
employed which may be transmitted as previously described, but also offer the advantage 
of being transmitted electronically to the GP. The discharge summary is a clinical and 
administrative document which serves many purposes, but the most important function is 
ensuring continuity of care through communication of information about a patient’s 
diagnosis, hospital management, medications and arrangements for post-discharge 
follow-up (van Walraven & Rokosh, 1999a). Timely transfer of accurate and relevant 
data may improve the continuity of care and reduce adverse events and unplanned 
readmission (van Walraven et al., 2002b). Communication of medicines between primary 
and secondary care should include complete and accurate lists of medicines the patient is 
prescribed. In addition, for patients being discharged from hospital, often there are 
medication changes, and these need to be communicated to the GP with reference to what 
the GP record is in order to facilitate continuity of patient care (Munday, Kelly, Forrester, 
Timoney, & McGovern, 1997). 
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1.4.2 Deficits in communication and information transfer on discharge 
 
Despite their importance, several studies have found communication of discharge 
information to be suboptimal, with deficiencies in discharge summary content (Tulloch, 
Fowler, McMullan, & Spence, 1975; Mageean, 1986; van Walraven & Weinberg 1995), 
accuracy (Macaulay, Cooper, Engeset, & Naylor, 1996), and timeliness (Mageean, 1986; 
van Walraven & Weinberg 1995). Often the discharge summary has been found to be 
poorly written, contain inaccurate or ineffective information, and received too late to be 
of any value. Delayed communication, incomplete information or inaccuracies in 
information transfer among healthcare professionals, particularly during the early post-
discharge period, may have substantial implications for continuity of care, patient safety, 
patient and clinician satisfaction, and resource use. Incomplete or inaccurate information 
can contribute to faulty medical decision-making or failure to adequately monitor a 
patient’s condition after discharge. 
 
 
1.4.2.1 Timeliness 
 
The discharge summary should ideally be received by the GP prior to the patient making 
a first contact with their GP after discharge from hospital, otherwise the GP is making 
decisions from a position of a ‘lack of information’ which is acknowledged as 
contributing to the risk of medication errors. As long ago as the mid-1970s, studies in the 
UK into communication between clinicians in primary and secondary care were 
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identifying deficits. Many of the early studies focused on investigating the rate of 
discharge summaries sent to GPs and the time it took to reach them, rather than defining a 
standard of timeliness. 
 
An early survey of communication between hospital consultants and GPs found that just 
over 80% of GPs said they had problems with the discharge letter; the main complaint 
was that letters arrive late, but significantly fewer consultants (36%) were aware of 
delays (Long & Atkins, 1974). Problems with communication were identified by both 
GPs and consultants. In one hospital, 70% of initial discharge letters failed to reach the 
GP within one week of the patient’s discharge, and 21% were more than four weeks late 
(Long & Atkins, 1974). Another study found that there was room for improvement in the 
time taken for final reports to reach the GP. They set the standard that an initial summary 
should arrive within three to four days of the patients discharge, and final reports should 
arrive within two weeks. The initial summary was received on average 4.3 days after the 
patient discharge, while the final report arrived on average 19.4 days after the patient left 
hospital (Tulloch et al., 1975). 
 
A study of one practice’s patients discharged from their local district general hospital, 
found that discharge summaries were received quicker if delivered by the patient. 
Discharge letters given to the patient to deliver by hand to their GP took an average of 
four days to arrive and 17% were never received; by contrast the average delay was 25 
days for discharge summaries posted to the GP and 25% were never received (Penney, 
1988). Similarly, another study found that discharge summaries given to patients to 
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deliver by hand arrived quicker (mean of two days) than when they were posted to the GP 
(mean of 4.5 days). At least 55% of summaries delivered by hand arrived within one day 
of discharge compared with 8% of those posted. The discharge summary was more likely 
to arrive if delivered by hand than posted; 4% of letters posted never arrived at the GP 
(Sandler & Mitchell, 1987).  
 
The problem of communication delays continued, and in 2002 a UK audit found that 60% 
of initial discharge summaries were received within five days of discharge and 52% of 
final discharge reports were received within four weeks (Foster et al., 2002).  
 
The problem of delayed communication of discharge information is not unique to the 
UK; it has been shown to be prevalent in studies from Canada (van Walraven & 
Weinberg, 1995; van Walraven et al, 2002a), and Australia (Wilson, Ruscoe, Chapman, 
& Miller, 2001). In 1995, van Walraven and Weinberg found that for medical patients 
only 49.1% of discharge summaries were received by the patient’s family physician (van 
Walraven & Weinberg, 1995). In 2001, Wilson et al found that GPs received discharge 
summaries for only 27.1% of patients (Wilson et al., 2001). A systematic review of 55 
observational studies published between 1970 and 2005 found that one week after 
discharge, a median of 53% (range 30%-94%) of initial discharge summaries had arrived 
compared with only 14.5% (range 9%-20%) of final discharge reports. In addition, 
approximately 11% of initial discharge summaries and 25% of final discharge reports 
never reached the primary care physician (Kripalani et al., 2007). 
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Of particular concern is that a number of studies since the mid 1980s have shown that 
after discharge from hospital, a significant proportion of patients contacted their GP for 
continuation of treatment before discharge information was received. This can lead to 
discrepancies post-discharge and the unintentional discontinuation of new medicines and 
recommencing of discontinued medicines. This was a particular problem where it was 
routine practice to only supply seven days of medicines to the patient on discharge. In the 
UK this has been partly mitigated by the re-engineering of hospital services and the 
change to one-stop-dispensing and the supply of 28-day original packs labelled for 
discharge (Audit Commission, 2001).  
 
In 1986, a study found that at one general practice over a three month period, 53% of the 
patients discharged from hospital contacted their GP before any discharge information 
had been received (Mageean, 1986). The median time interval from discharge to receipt 
of the initial discharge summary by the GP was eight days, and no communication was 
received for 11% of admissions. A cohort study of medical patients discharged from a 
hospital in Canada found that discharge summaries were only available for 15% of 
follow-up visits (van Walraven et al., 2002a). Reasons for delays in the GP receiving the 
discharge document included system errors such as delays in it being written or dictated 
by the doctor (van Walraven & Weinberg, 1995), delays in it being typed due to 
secretarial availability to transcribe dictation (Penney, 1988; van Walraven & Weinberg, 
1995), not being sent (van Walraven et al., 2002a; Wilson et al., 2001), it was never 
written or missing (Bertrand, Francois, Bosson, Fauconnier, & Weil, 1998; van Walraven 
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& Weinberg, 1995; Wilson et al., 2001), or it was sent but not received (van Walraven et 
al., 2002a).  
 
Recent studies in the UK by the NHS Alliance and CQC have found that the problem is 
continuing. A survey by the NHS Alliance reported that 70% of GP practices were sent 
discharge summaries late, either ‘very often’ or ‘fairly often’, and 39% of practices 
reported instances where this failing had directly compromised patient safety (NHS 
Alliance, 2007). A recent study by the CQC found that only 53% of the GP practices 
surveyed reported that discharge summaries were received in enough time to be useful 
either ‘all of the time’ or ‘most of the time’ for a patient’s first follow-up GP appointment 
(CQC, 2009). 
 
 
1.4.2.2 Content of the discharge summary 
 
Even when the discharge summary is received in a timely manner, the content may be 
incomplete or inaccurate i.e. essential information may be missing or incorrect. Common 
discrepancies associated with incomplete content of the discharge summary include 
missing information such as: omission of medications; omission of allergies; failing to 
provide a rationale for why a patient’s medication had been changed; and the absence of 
follow-up plans. Common discrepancies associated with inaccurate content of the 
discharge summary include incorrect information such as: wrong form, dose or frequency 
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of discharge medication; wrong allergies information; and wrong information about 
medication changes. 
 
In 1974, a study of the content and design of initial and final discharge reports concluded 
that there was room for improvement, both in the type and amount of information 
recorded, and in the presentation of this information (Tulloch et al., 1974). There was no 
record of drugs supplied by the hospital to the patient on discharge in 90% of initial 
summaries and 81% of final reports. Drug reactions were reported in only 2% of initial 
summaries and almost 10% of final reports. 
 
Although problems with discharge communication have been identified for many years, 
similar results are still being reported as the problem is still recurring. Two studies almost 
twenty years apart identified that information in discharge summaries was often 
incomplete and sometimes inaccurate, and there was a need for improvement in the 
communication between the hospital and the GP (Mageean, 1986; Sackley & Pound, 
2002). Sometimes essential information such as the diagnosis or medication was missing. 
Similarly Foster et al found that basic information was lacking in up to 30% of discharge 
summaries; 13% failed to record a main condition or diagnosis and 93% recorded some 
medication information but were incomplete (Foster et al., 2002). 
 
The problem of accuracy and completeness of information about medicines has been 
specifically studied and is not unique to the UK; it has been shown to be prevalent in 
studies from the USA (Rao, Andrei, Fried, Gonzalez, & Shine, 2005), Canada (van 
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Walraven & Weinberg, 1995), Australia (Wilson et al., 2001), New Zealand (McMillan, 
Allan, & Black, 2006), and Europe.  
 
A systematic review of 55 observational studies published between 1970 and 2005 found 
that the final discharge report often did not identify the responsible hospital physician 
(missing from a median of 25%), the main diagnosis (17.5%), other diagnoses (28%), 
presenting symptoms (20%), diagnostic test results (38%), treatment/hospital course 
(14.5%), discharge medications (21%), and specific follow-up plans (14%). The highest 
rates of missing information were observed with tests pending at discharge (65%) and 
counselling provided to patients or families (91%) (Kripalani et al., 2007). Audits of the 
initial discharge summary similarly showed the highest rates of missing information were 
observed with tests pending at discharge (88%) and counselling provided to patients or 
families (92%); in addition, legibility was a concern in 10% to 50%. Missing or incorrect 
information occurred more frequently in the case of treatment/hospital course (missing 
from a median of 29.5%), discharge medications (25%), follow-up plans (30%) 
diagnostic test results (65%) and presenting symptoms (48.5%). It concluded that deficits 
in communication and information transfer at hospital discharge were common (Kripalani 
et al., 2007).  
 
A recent study in the UK by the CQC found that 81% of the GP practices surveyed 
reported that details of prescribed medicines were incomplete or inaccurate on discharge 
summaries ‘all of the time’ or ‘most of the time’ (CQC, 2009). 
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1.4.2.3 Preparation of the discharge summary 
 
The discharge summary is most frequently prepared by junior doctors and this may 
contribute to the frequency of errors and suboptimal quality. A study at Aberdeen Royal 
Infirmary found that junior doctors made more errors on surgical discharge summaries 
than registrars or consultants (Macaulay et al., 1996). Another study of senior house 
officers’ experience of preparing discharge summaries found that there was a lack of 
guidance and little opportunity for formal feedback; discharge summaries were often 
given a low priority and quality was suboptimal (Frain, Frain, & Carr, 1996). 
 
 
1.4.3 High quality discharge summaries 
 
Research, previously described, has demonstrated that there are clear deficiencies in the 
timeliness and content of discharge summaries. Hospital discharge summaries have been 
described as of high quality when they were short, contained pertinent data that 
concentrated upon discharge information, and were delivered quickly (van Walraven & 
Rokosh, 1999a). Information about discharge medications has been identified by GPs as 
being important for providing adequate follow-up care, and essential for inclusion in the 
discharge summary (Kripalani et al., 2007). The quality of information about medicines 
in the discharge summary is an important indicator of quality of care, as it can influence 
continuity of care when patients are discharged from hospital. The quality of medicines-
related information in the discharge summary is therefore, for the purpose of this report, 
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defined as medicines-related information that is complete, accurate, and written in a 
timely manner. What comprises complete, accurate and timely medicines-related 
information will be outlined in the following sections.  
 
 
1.4.3.1 Structure of the discharge summary 
 
A structured format, rather than purely narrative reports in which important information 
is given no special emphasis, is preferred for the discharge summary. The majority of 
GPs preferred a structured discharge summary because of completeness, readability, 
conciseness and the ease of locating key documentation (Archbold et al., 1998; van 
Walraven, Duke, Weinberg, & Wells, 1998; van Walraven, Laupacis, Seth, & Wells, 
1999b). 
 
 
1.4.3.2 Timeliness 
 
The NHS Standard Contract, which became operative from 1
st
 April 2008, introduced a 
new national standard that required acute hospitals to ensure that each patient received a 
discharge summary at the time of discharge, and issued a discharge summary to the 
patient’s GP within 72 hours of discharge (NHS Alliance, 2009a). This standard changed 
to within 48 hours from 1
st
 April 2009 and within 24 hours from 1
st
 April 2010. To 
achieve this standard it is essential that the discharge summary be written prior to the 
 38 
time of discharge. Failure to achieve this standard puts hospitals in breach of their 
contract and they can be penalised financially; despite this, surveys by the NHS Alliance 
and CQC have found that about half of GPs are not getting discharge letters on time 
(NHS Alliance, 2009b; CQC, 2009).  
 
 
1.4.3.3 Content of the discharge summary 
 
Unequivocal information on the hospital department, the consultant, and the name and 
status of the reporting doctor makes contact between the GP and the hospital much easier. 
A number of studies have examined what GPs perceive as being the important data items. 
A systematic review identified that GPs rated the following information as most 
important for providing adequate follow-up care: main diagnosis; pertinent physical 
findings; results of procedures and laboratory tests; discharge medications, with reasons 
for any changes to the previous regimen; details of follow-up arrangements made; 
information given to the patient and family; test results pending at discharge; and specific 
follow-up needs (Kripalani et al., 2007). 
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1.4.3.4 Medicines-related information in the discharge summary 
 
Common discrepancies with discharge information include the omission of medications, 
failing to provide a rationale for why a patient’s medication had been changed and the 
absence of follow-up plans. There is a need to transfer more information than a list of 
current drugs; changes made to treatment and the reasons for those changes should also 
be communicated. Both GPs and community pharmacists want to receive information on 
the reasons for medication changes in hospital (Munday et al., 1997). This should also 
include information about drugs which have been tried and found to be ineffective, or 
have caused adverse reactions. A survey of GPs in Kent found that 84% of GPs 
“occasionally” or “never” received information about why medicines had been altered in 
hospital, and this was their biggest medicines information need (Brackenborough, 1997). 
This supported findings of an earlier study which found GP confusion over continuation 
of medication post-discharge, and not carrying through changes made to medication 
during the patient’s hospital admission (Solomon, Maxwell, & Hopkins, 1995). 
 
A number of guidelines have now been published in the UK by the Scottish 
Intercollegiate Guidelines Network (SIGN), the British Medical Association (BMA) and 
the Academy of Medical Royal Colleges, which recommend a minimum dataset of 
information that should be included in the discharge summary (SIGN, 2003; British 
Medical Association [BMA], 2007; Academy of Medical Royal Colleges, 2008). The 
medicines-related information recommended by the three guidelines for inclusion in the 
discharge summary are summarised in Table 1. To provide structure the medicines-
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related information in the table was grouped according to the key headings used by the 
Academy of Medical Royal Colleges guideline. What was evident was that no single 
guideline provided a comprehensive list of the medicines-related information that should 
be included in the discharge summary. SIGN guideline 65 was the most complete, but 
defined some information as essential and others as desirable (indicated by italics), and 
did not mention medication recommendations which the Academy of Medical Royal 
Colleges included. The BMA guideline was the least complete, it provided a template of 
a model discharge letter from a hospital doctor to a GP, which included a brief 
recommendation for medicines-related information and then referred to accessing SIGN 
guideline 65 for further suggestions on information that might be useful to include in 
discharge letters. On balance it would seem reasonable to define a comprehensive list of 
the medicines-related information that should be included in the discharge summary as: 
all items defined as essential in SIGN guideline 65; plus desirable information that also 
appeared in either the BMA or Academy of Medical Royal Colleges guidelines (indicated 
by shaded sections of table). 
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Table 1: Medicines-related information recommended for the discharge summary 
Headings SIGN guideline 65, 
2003 
BMA guideline, 
2007 
Academy of Medical Royal 
Colleges standards, 2008 
Allergies Adverse reactions, 
including all known 
allergies 
Reactions or 
allergies to drugs 
Allergies, drug allergies and 
adverse reactions 
Discharge 
medications 
Name of drug (generic 
where possible) 
Medication details Can include medication 
dispensed on discharge, 
medication prescribed and 
not dispensed (e.g. patient’s 
own), and medications to be 
commenced after discharge 
Formulation, current 
dose, frequency and 
length of treatment 
  
Route of administration   
Supply given to patient   
Compliance aids 
required or already 
given to the patient 
should be provided - 
detail whether being 
used or not. 
 Can include NOMAD / pill 
dispenser being used 
Medication 
changes 
Dose changed See below  
Drug stopped Drugs the patient 
has stopped taking 
See below 
New prescription Drugs the patient 
has started taking, 
and whether this 
should continue 
See below 
Start and stop dates for 
short or defined courses 
of treatment (where 
relevant) 
  
Reasons for starting 
and stopping (where 
relevant) 
Reasons for 
medication changes 
if applicable 
If admission medication 
stopped need to state reason. 
If medication started and 
stopped because of adverse 
reaction need to state reason 
Relevant 
treatments and 
changes made to 
treatments 
  The relevant treatments 
which the patient received 
during the inpatient stay. 
Can include medications 
given whilst an inpatient 
Medication 
recommendation 
  A suggestion made for 
starting, discontinuing, 
changing or avoiding items 
in a patient’s medication 
record 
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1.4.3.5 The immediate discharge document (IDD) 
 
SIGN first published guideline five in 1996 which proposed a minimum dataset for the 
IDD or discharge summary. This was superseded in 2003 by guideline 65 with a revised 
minimum dataset. The IDD is an important tool for communication between secondary 
and primary care that should be available at the time of patient discharge. The content of 
the minimum data set includes items that are considered essential as well as those that are 
desirable. The guideline also makes recommendations about the format of the IDD, who 
should complete it, who should receive it and how it should be transmitted (SIGN, 2003). 
The IDD is not intended to be a standard of care; rather a standard of documentation.  
 
 
1.4.3.6 Improving communication, the exchange of information and patient care 
 
In 2007, the BMA published suggested guidelines for hospital doctors and GPs. It 
recommended that the immediate discharge summary should include all important 
information such as: basic administrative details (full details of patient, GP and hospital); 
reason for admission and type; diagnosis; admission and discharge dates; ward; name of 
consultant; important procedures carried out; important test results (known and pending); 
medication; follow up arrangements; information given to the patient; and contact details 
(BMA, 2007).  
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1.4.3.7 A clinician’s guide to record standards 
 
In 2008, the Academy of Medical Royal Colleges published standards for the structure 
and content of medical records and communications when patients are admitted to 
hospital. It included comprehensive standards that were developed for the discharge 
summary (Academy of Medical Royal Colleges, 2008). 
 
 
1.4.3.8 The electronic discharge summary 
 
The use of electronic discharge summaries (EDSs) has been proposed as a method of 
improving discharge communications (Kripalani et al., 2007), and probably offers the 
only viable option for achieving the discharge summary targets set out in the NHS 
Standard Contract. The EDS allows clinical staff automatically to create a structured, 
legible, complete and accurate discharge summary, ready to be printed and given to 
patients as they depart from the hospital. The EDS can be simultaneously transmitted to 
clinical databases and GPs to improve the flow of patient information between secondary 
and primary care providers. Benefits include: standardised documentation quality; 
completeness; improved legibility; streamlined clinical workflow; and timely 
communication of electronic information to other healthcare providers (Craig, Callen, 
Marks, Saddik, & Bramley, 2007). 
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There are fewer published studies of the quality of EDSs compared to traditional paper-
based (handwritten or typed) discharge summaries. A survey of GPs in New Zealand 
identified that the following medicines-related information should be in the EDS: 
discharge medications (92%); reasons for any changes to medications (70%), and; 
admission medications (24%) (Hopcroft & Calveley, 2008). Accuracy of the information 
was a major concern among GPs, as well as timeliness; the EDS should be sent to the GP 
on the day of discharge. The problem of inaccuracy of discharge medications (type and 
dosage) and the frequent absence of a rationale for medications being changed was 
highlighted (Hopcroft & Calveley, 2008). 
 
Studies conducted in the USA,  Canada, Australia and UK have demonstrated benefits in 
quality (O’Leary et al., 2009; Maslove et al., 2009) as well as timeliness of preparation of 
the discharge summary (O’Leary et al., 2009; van Walraven & Rokosh, 1999a; Alderton 
& Callen, 2007). A pre-post evaluation of the quality and timeliness of a newly created 
EDS in a US hospital concluded that it significantly improved the quality and timeliness 
of discharge summaries; although timeliness remained less than optimal (O’Leary et al., 
2009). However, quality of medicines-related information was not defined beyond listing 
discharge medications, and introduction of the EDS did not significantly improve the 
documentation of discharge medications (O’Leary et al., 2009). A survey of GPs in 
Australia to assess satisfaction with the quality of information in the EDS and the 
timeliness of receipt, concluded that it was an improvement over the manual discharge 
summary; although timeliness was defined as the EDS received within two weeks 
(Alderton & Callen, 2007). However, discharge medications were handwritten, and then 
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transcribed onto the medication field on the EDS, and the EDS was printed and processed 
like a traditional discharge summary.     
 
It is not necessarily the case that EDSs are of a high quality (Kazmi, 2008), and two 
studies by the same researchers found that EDSs contained a higher number of errors or 
omissions than handwritten discharge summaries (Callen et al., 2008; Callen, McIntosh, 
& Li, 2010). Callen et al checked all discharge medications for completeness and 
accuracy and found that this occurred less frequently with the EDS (87%) compared with 
the handwritten discharge summary (94%) (Callen et al., 2008). A later study identified 
that the types of medication errors in the EDS included: medication omitted; additional 
medication listed; frequency different; dose different; dose omitted, and; frequency 
omitted (Callen et al., 2010). Transcription error was the common contributing factor, 
whether the discharge summary was handwritten or typed, and this may arise because in 
these studies the EDS required manual entry of medication data (Kazmi, 2008; Callen et 
al., 2008; Callen et al., 2010).  
 
In the next sections, the setting of the research and its aims and objectives are described. 
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1.5 Winchester and Eastleigh Healthcare NHS Trust 
 
Winchester and Eastleigh Healthcare NHS Trust (WEHCT) manages two hospitals, the 
Royal Hampshire County Hospital (RHCH) and Andover War Memorial Hospital 
(AWMH).  
 
The RHCH is located in Winchester and is the main acute hospital for the area, with 
approximately 400 inpatient beds. It provides a full range of general hospital services: 
accident and emergency; general and specialist surgery for in-patients and day cases; 
general medical facilities; intensive care; rehabilitation for inpatients and day cases; 
chemotherapy; diagnostic facilities; outpatient clinics; paediatric care; a large maternity 
unit and a neonatal unit; . The Hampshire Partnership NHS Trust also has an acute mental 
health facility, Melbury Lodge, on the RHCH site.  
 
The AWMH is located in the centre of Andover and provides a range of community and 
hospital services, including minor injuries unit, outpatients, in-patient rehabilitation, 
diagnostic imaging, day surgery and the Andover Birth Centre. The Andover site is also 
home to the Countess of Brecknock House Hospice which provides six in-patient beds, 
day care facilities and a base for the Macmillan nurses. 
  
Clinical services at WEHCT are managed through four divisions: medicine and elderly 
care; surgery and anaesthetics; family services; and diagnostics. Pharmacy services are 
within the diagnostics division. 
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The health authority which covers the area WEHCT works in is NHS South Central, and 
the Primary Care Trust (PCT) which commissions the majority of services is NHS 
Hampshire.  
 
1.5.1 NHS South Central 
 
NHS South Central is one of ten Strategic Health Authorities across the country; it covers 
the counties of Berkshire, Buckinghamshire, Oxfordshire, Hampshire and Isle of Wight 
as illustrated in Figure 1.  
 
1.5.2 Hampshire PCT 
 
Hampshire PCT serves about 1.25 million people; covering the Basingstoke and Deane, 
East Hampshire, Eastleigh, Fareham, Gosport, Hart, Havant, New Forest, Rushmoor, Test 
Valley and Winchester areas. Its boundaries are the same as the county of Hampshire, 
excluding the cities of Southampton and Portsmouth which are each covered by a 
different PCT. 
 
WEHCT is located central to the population covered by Hampshire PCT and provides a 
complex range of care for around 350,000 people living in Mid Hampshire; 
predominantly Winchester, Eastleigh, Andover, Stockbridge, Bishops Waltham, 
Arlesford and the surrounding area. 
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Figure 1: Map outlining area covered by the South Central Strategic Health 
Authority. 
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1.5.3 Electronic Prescribing and Medication Administration at the RHCH 
 
In September 2006, WEHCT became the first UK trust to replace an existing Electronic 
Prescribing and Medication Administration (EPMA) system with a second generation 
system. WEHCT replaced the legacy e-prescribing system ‘TDS Desktop 7000’ with the 
implementation of the JAC EPMA system at the RHCH; including Melbury Lodge which 
was on the RHCH site but within the Hampshire Partnership NHS Trust. AWMH was not 
part of the implementation and continued to use a paper prescribing system.  
 
The RHCH was the first hospital in the UK to implement electronic prescribing in 1988, 
thus being the first NHS Trust to replace its paper (drug chart) prescribing system with 
the TDS integrated Hospital Information System (HIS). WEHCT was one of a handful of 
NHS hospital trusts, together with Wirral and Burton, which implemented TDS and 
Meditech systems incorporating electronic prescribing as part of HIS pilots in the 1980s.  
 
The implementation of the JAC EPMA system in 2006 was in support of the trust’s on-
going plans to replace the HIS system in parallel with other replacement systems supplied 
by the National Programme for IT (NPfIT). In February 2007, WEHCT also implemented 
the Fujitsu Release Zero Cerner Millennium clinical system supplied by NPfIT. The 
Cerner Millennium patient administration system did not include electronic prescribing as 
part of Release Zero. 
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The JAC EPMA system combined with the trust’s existing JAC Pharmacy Management 
module, provides the benefit of a fully integrated medication management solution (JAC, 
2007). The JAC system assists in the entire cycle of medicines management from 
prescribing, clinical verification and supply, to nurse administration of medicines.  The 
system incorporates decision-support from First Data Bank Europe (FDBE), and provides 
real-time alerts for potential medical errors including drug allergies, drug-drug 
interactions and therapeutic duplicates (JAC, 2007). A more detailed description of the 
functionality of the JAC system, which is germane to this thesis, is provided in Appendix 
1. Ward based staff at the RHCH use mobile computers on the Trust’s wireless network, 
in addition to fixed terminals, to view data, prescribe and administer medicines. These 
terminals, known as Computers on Wheels (COWs), enable healthcare staff to prescribe 
and administer medicines at the bedside and spend more time with patients, reducing 
errors and improving the patient experience. The EPMA system supports the key aim of 
the NPfIT to give healthcare professionals safe, secure and timely access to patient 
information, whenever and wherever it is needed (Connecting for Health, 2007). 
 
 
1.5.4 Quality of discharge summaries at WEHCT 
 
In September 2009, Hampshire GP practices conducted a survey of discharge summaries 
from the seven acute providers that NHS Hampshire commissions care from. The 
discharge summaries were assessed for their completeness, timeliness of arrival, and 
legibility, using a survey tool designed by the NHS Hampshire Quality and Patient 
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Experience team and clinical leads based on the Academy of Medical Royal Colleges 
guidance published in 2008 (NHS Hampshire, 2010). Comparison of WEHCT’s results 
with the local mean highlighted areas of good practice, and also specific areas where 
improvement could be made. WEHCT performed above the local mean in terms of 
timeliness (51%) and legibility (100%), but marginally below the local mean on overall 
completeness (65%). WEHCT performed above average in all the medication categories 
including medication changes (58%), discharge medications (70%) and medication 
recommendations (63%); data on allergies information were not collected in the survey 
(NHS Hampshire, 2010). Therefore, use of an EDS at WEHCT does not guarantee the 
timeliness or completeness of the discharge summary, and the survey measured the 
presence of data and not its accuracy. 
 
 
1.6 The research question 
 
Information technology may offer an integrated solution to ensuring the safe transfer of 
care, by facilitating the writing of the discharge summary and prescription, and the timely 
dissemination of discharge information. Research into the quality of information, and in 
particular medicines-related information, in the EDS was scant, mostly conducted in the 
USA and Australia, and was limited to the study of EDSs prepared by transcription of 
information onto a template (O’Leary et al, 2009, Callen et al, 2008). Although EDSs 
offer a solution to the production of timely, complete and accurate discharge medication 
information, there are conflicting findings when assessing the quality of the discharge 
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summary (O’Leary et al, 2009, Callen et al, 2008). The lack of clear definitions of what 
comprises high quality medicines-related information in the discharge summary, in 
addition to manual entry of data onto the EDS, contributes to these conflicting findings. 
WEHCT uses an EDS system where the majority of the medicines-related information is 
pre-populated and the minority is manually entered, and a recent survey showed that, 
although better than the local average, there were deficiencies in completeness and 
timeliness (NHS Hampshire, 2010).  
 
Therefore, the research question is: How much medicines-related information is in the 
EDS, and is it complete and accurate, and written in a timely manner? 
 
 
1.7 Aims and objectives 
 
Aims 
  
1. To list and describe the content of medicines-related information in the electronic 
discharge summary. 
2. To evaluate the quality of medicines-related information in the electronic 
discharge summary for completeness, accuracy and timeliness. 
3. To evaluate the quality of information about medication changes in the electronic 
discharge summary for completeness and accuracy. 
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Objectives 
 
1. To define the key medicines-related information necessary for a high quality 
discharge summary. 
2. To measure the content and timeliness of medicines-related information in the 
electronic discharge summary over a two month period at the Royal Hampshire 
County Hospital. 
3. To identify variables that affect the quality of medicines-related information in the 
electronic discharge summary. 
4. To assess the construct validity of the coding of medication changes. 
5. To assess the reliability of the coding of medication changes. 
6. To make recommendations about how the quality of medicines-related 
information in the electronic discharge summary could be improved. 
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Section 2 Method 
 
2.1 Study design 
 
A non-experimental fixed design was used for the purpose of meeting the aims and 
objectives of the study. A non-experimental approach was used as the researcher was 
measuring the medicines-related information, and was not deliberately manipulating or 
changing the content of the EDS. As the purpose of the evaluation was to assess the 
quality of medicines-related information in the EDS, a fixed design strategy was 
indicated (Robson, 2002). 
 
The study method used was a prospective content analysis (Robson, 2002) of medicines-
related information in a sample of EDSs generated in WEHCT. A randomly selected sub-
group of this sample of EDSs was then used to evaluate the information about medication 
changes for construct validity and inter-coder reliability. An overview of the study design 
is shown in Figure 2.1, and is described in further detail in Sections 2.2 to 2.13. 
 
Content analysis is a methodology used in the social sciences for studying the content of 
communications and is a common approach used in documentary analysis (Robson, 
2002). It enables the analysis of the content of a document in an unobtrusive and non-
reactive way, i.e. the document is not affected by the fact you are using it (Robson, 2006). 
Reliability and validity are central concerns in content analysis. When human coders are 
used in content analysis, problems can arise in intra-coder (single coder) and inter-coder 
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(two or more coders) reliability. There may be differences in the degree of inference 
which the coder has to make when categorising items. This is sometimes expressed in 
terms of manifest content and latent content, corresponding to low and high inference 
items respectively (Robson, 2002). Manifest items are those which are physically present 
(e.g. a particular word); latent content is a matter of inference or interpretation on the part 
of the coder. 
 
Content analysis was judged to be appropriate, as the aims of the study were to: list and 
describe the content of medicines-related information in the EDS; evaluate the quality of 
medicines-related information in the EDS for completeness, accuracy and timeliness, 
and; evaluate the quality of information about medication changes in the EDS for 
completeness and accuracy. The following definitions were made for the purpose of the 
study. Completeness was defined as medicines-related information that had no omissions 
of essential content; including allergies, discharge medications, and medication changes 
(as shown in Table 2.2). Accuracy was defined as medicines-related information that had 
no ambiguous, duplicate or incorrect content. Timeliness was defined as the EDS being 
prepared and printed ready for issue at the point of discharge. In addition, completeness 
and accuracy of information about medication changes was defined as information that 
identified all medication changes and gave reasons for changes that were interpreted as 
being rational. Information about medication changes has a high degree of latent content 
and thus was tested for construct validity and inter-coder reliability. 
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Figure 2.1: Overview of the study design 
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2.2 Object of study 
 
EDSs generated on the JAC EPMA over a two month period from 1
st
 July to 31
st
 August 
2010, associated with an inpatient episode of care and subsequent discharge from the 
JAC system. Data was collected during July and August in order to ensure that the EDS 
sample represented EDSs prepared by doctors who were experienced in preparing them 
as well as doctors, after the rota change in August, who were relatively inexperienced in 
doing so. 
 
An example of the EDS generated on the JAC system is shown in Appendix 2. The EDS 
contains sections for GP details, patient details, admission details, discharge medications, 
and ‘discharge letter notes’, as well as recording details of the preparation of the EDS. 
Some of the data on the EDS is pre-populated, and some is manually entered, as 
described in Appendix 1, Section 1.2.9. The EDS is generated with the specific purpose 
of communicating essential clinical and administrative information to the GP when the 
patient is discharged following an episode of inpatient care. As such it contains more 
information that just medicine-related information, and some medicines-related 
information may have to be interpreted within the context of information contained 
within the whole EDS. Some medicines-related information could be coded by the 
presence of a particular word or phrase e.g. ‘no known drug allergies’ or a drug name in 
the allergies sub-section of the patient details section of the EDS. Some medicines-related 
information could be coded by a particular item of information being present e.g. 
pharmacist letter notes entered in the ‘discharge letter notes’ section of the EDS. Some 
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information required coding of manually entered content e.g. information about 
medication changes, a particular phrase may indicate a medication changes note, but the 
meaning within the context of medication changes had to be interpreted by the coder 
taking into account the wider content of the EDS. Further details of analysis of the 
document and coding of content are described in section 2.9.  
 
 
2.3 Setting and roles of the multi-disciplinary team 
 
The setting of the study was WEHCT, which comprises two hospital sites: the RHCH and 
AWMH. WEHCT has a ‘Discharge Operational Policy’ which aims to assist staff in 
ensuring effective, timely and safe discharges from hospital for all patients (Winchester 
and Eastleigh Healthcare NHS Trust [WEHCT], 2009). The policy relates to all patient 
groups including adult orthopaedics, adult surgical, adult medical, rehabilitation, and 
cancer care patients; but excluding paediatric and maternity patients which use their own 
local discharge policies. The roles and responsibilities of the multi-disciplinary team in 
managing all aspects of the discharge process are clearly defined. The ward manager has 
overall responsibility for ensuring that the discharge planning process is followed by all 
nursing staff for all patients. The named nurse for each patient is responsible for co-
ordinating a patient’s discharge. The lead consultant in charge of the patient’s care is 
responsible for the medical discharge of the patient. The medical team is responsible for 
confirming in the medical notes that the patient is fit for discharge, prescribing discharge 
medication (TTA), and completing the EDS. Some pharmacists at WEHCT may write 
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TTAs on behalf of the medical team, when they have attended the team rounds, and detail 
significant medication changes made during the patient stay in hospital on the EDS, to 
improve communication with GPs. The nursing and medical teams are jointly responsible 
for ensuring that information about the patient is communicated quickly and efficiently to 
the primary healthcare team. During the patient’s stay in hospital medicines-related 
information is documented in a combination of paper and electronic records by the 
multidisciplinary team, and can be retrieved to facilitate medicines management. A 
summary of the processing of medicines-related information from admission to discharge 
is shown in Figure 2.2. 
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Figure 2.2: The processing of medicines-related information from admission to 
discharge 
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2.4 Inclusion and exclusion criteria 
 
The setting of the study was WEHCT; therefore, only EDSs from wards at WEHCT were 
included. Wards at Melbury Lodge, which used the same JAC system to prescribe and 
generate EDSs, were excluded as they were a different healthcare trust. The object of the 
study was the EDS; therefore, only discharge summaries prepared using the JAC system 
were included. This meant that wards at AWMH were excluded as the JAC EPMA was 
not implemented there. Similarly, ward S5 at the RHCH was excluded as it used an 
electronic proforma instead of the JAC system to generate discharge summaries. In 
addition, paediatric and maternity wards were excluded, as they were excluded from the 
WEHCT discharge operational policy. The resulting list of WEHCT wards included in 
the study encompassed all three divisional specialities at the RHCH as shown in Table 
2.1.  
 
The content of interest in the EDS was medicines-related information therefore at least 
one TTA item had to be prescribed on the JAC system for the EDS to be included; 
Section 2.5 describes how EDSs eligible for inclusion were identified in the dispensary. 
In order to ensure that the data collected from the EDS was not subject to change, the 
inpatient episode of care associated with the EDS must have been discharged from the 
JAC system within the study period. Information could be altered at any point prior to 
discharge from the JAC system; after discharge no further changes could be made.  
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Table 2.1: WEHCT wards included in or excluded from the study 
Ward code Site Speciality Division Included / 
excluded 
F1 RHCH Gynaecology / 
surgery 
Family services 
(FS) 
Included 
M1 RHCH Cardiology Medicine and 
care of the 
elderly (M&E) 
Included 
M2 RHCH Rehabilitation M&E Included 
M3 RHCH Medical 
admissions 
M&E Included 
M4 RHCH Stroke unit M&E Included 
M5 RHCH Respiratory M&E Included 
M6 RHCH Elderly care M&E Included 
M7 RHCH Gastroenterology 
/ endocrinology 
M&E Included 
S1 RHCH Orthopaedics Surgery and 
anaesthetics 
(S&A) 
Included 
S2 RHCH Surgery S&A Included 
S3 RHCH Surgery / 
orthopaedics 
S&A Included 
S4 RHCH Short stay 
surgery 
S&A Included 
M8 AWMH Palliative care M&E Excluded 
M9 AWMH Rehabilitation M&E Excluded 
S5 RHCH Intensive care S&A Excluded 
F2 RHCH Maternity FS Excluded 
F3 RHCH Maternity FS Excluded 
F4 RHCH Neonatal unit FS Excluded 
F5 RHCH Paediatrics FS Excluded 
 
As the validity and reliability of the information on medication changes was being 
evaluated, a further inclusion criterion was that a ‘drug history note’ was documented on 
JAC, in addition to the TTA being screened in the dispensary. The assumption made was 
that a ‘drug history note’ was evidence of medicines reconciliation at admission, and that 
the TTA being screened in the dispensary was evidence of medicines reconciliation at 
discharge; i.e. reconciliation of the TTA and inpatient prescription.   
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2.5 Selection of the EDS sample 
 
Dispensing records in pharmacy were used to identify TTA dispensing lists from 
included wards that were then screened by the researcher for eligibility for the study. 
Identifying the EDS from dispensing records allowed for the assumption that any 
discrepancies in the TTA would have been identified by a pharmacist and an intervention 
made prior to retrieval of the EDS for content analysis. The hospital medical record 
number on the TTA dispensing list was used to retrieve the EDS and ‘drug history note’ 
from the JAC system. If the episode of care had not been discharged from the JAC 
system prior to 1
st
 September 2010, or there was no ‘drug history note’ recorded on the 
JAC system, then the EDS was excluded from the study. Each EDS could only be 
included once. Data were anonymised; each eligible EDS (i.e. met all inclusion criteria) 
was assigned a unique identification number consisting of a code representing the ward 
from which the patient was discharged and a number allocated sequentially by date of 
discharge. Data were collected from the EDSs as outlined in Section 2.10. 
 
 
2.6 Selection of EDSs for assessment of construct validity 
 
A stratified random sample of 10% of the EDSs were selected; and stratified to ensure 
proportionate sampling by ward. A 10% sample was chosen to ensure the EDSs being 
further assessed for construct validity was a manageable number, given that the EDS 
sample covered a two month period and had already been pre-selected to only include 
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EDSs that had an associated ‘drug history note’ recorded on the JAC EPMA. A number 
between zero and nine was chosen at random using a random number list, and the EDS 
was selected where that number appeared as the final digit of the unique identification 
number. The construct validity of the information about medication changes was assessed 
by comparing the ‘discharge medication’ list on the EDS with the ‘drug history note’ on 
the JAC EPMA, to identify if medication changes had occurred before analysing if these 
changes were listed and the reasons for changes stated completely and accurately. Data 
were collected from the EDS and ‘drug history note’ as outlined in Table 2.5. 
 
 
2.7 Selection of EDSs for assessment of inter-coder reliability 
 
The inter-coder reliability of the information about medication changes was assessed by 
comparing the coding of medication changes by the researcher with the coding by a 
second coder; who was a speciality clinical pharmacist at WEHCT. The second coder 
independently analysed a random sample of 30 of the EDS sample used for construct 
validity; EDSs were selected using a random number list. A sample size of 30 (which was 
approximately 20% of the EDS sample for construct validity) was chosen to ensure the 
number of data points exceeded the minimum number required for statistical analysis. 
Data were collected from the EDS as outlined in Table 2.5, and matched responses by 
both coders were compared by calculating the kappa statistic. 
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2.8 Selection of categories of medicines-related information for analysis 
 
The categories of medicines-related information were selected using the 
recommendations of the three national guidelines summarised in Table 1 (SIGN, 2003; 
BMA, 2007; Academy of Medical Royal Colleges, 2010). These were then checked 
against the local discharge policy (WEHCT, 2009), and recommendations of the Wessex 
Local Medical Committees (Watson, 2006) to ensure consistency. Five key themes, or 
categories, of medicines-related information at discharge emerged: allergies; discharge 
medication; medication changes; medications which the patient received during the 
inpatient stay; and medication recommendations. Essential categories of medicines-
related information were defined as allergies, discharge medication and medication 
changes; as they were consistently listed in the guidelines. Medication recommendations 
and medications which the patient received during the inpatient stay were defined as 
desirable content as they were recommended in only one guideline. The definition of 
each of the categories, along with the source of this information within the context of the 
EDS, is outlined in Table 2.2. 
 
Information about medication changes has a high latent content and thus was further 
analysed for construct validity and inter-coder reliability, as outlined in Sections 2.6 and 
2.7.  
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Table 2.2: Categories and definitions of medicines-related information in the EDS 
Category 
 
Definition Source of data 
Allergies Allergies, drug allergies and adverse 
reactions. 
‘Allergies’ data  
field of EDS 
Discharge medication Medications prescribed for discharge, 
including medications dispensed for 
discharge, patient’s own medicines, and 
compliance devices. Details should 
include name of drug, form, dose, 
frequency, length of treatment and 
whether ‘GP to continue’.  
‘Discharge 
medication’ data 
field of EDS 
Medication changes Medication changes include: 
- admission medication stopped 
- admission medication dosage 
changed 
- new medication started 
Reasons for starting, stopping or changing 
medications should be stated. 
‘Discharge letter 
notes’ in the EDS 
Medications which the 
patient received during 
the inpatient stay 
Medication prescribed for administration 
during the inpatient stay which is 
documented as a relevant treatment. This 
may include medication started and 
stopped either because of adverse reaction 
or treatment concluded. 
‘Discharge letter 
notes’ in the EDS 
Medication 
recommendations 
Suggestions made for starting, stopping, 
changing or avoiding medication. The 
medication recommendation may be made 
to another clinician or directly to the 
patient. 
‘Discharge letter 
notes’ in the EDS 
 
 
2.9 Content analysis instrument 
 
The content analysis instrument was designed to categorise and code data from the EDS 
in a systematic and objective manner. A standardised document abstraction form was 
used by the researcher to collect information about the content of medicines-related 
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information in the EDS, and whether it was complete, accurate and prepared in a timely 
way. 
 
The content being analysed was broadly grouped under five headings: general 
information; preparation of the EDS; medicines-related information in the EDS; 
information about medication changes, and; inter-coder reliability. The general 
information was collected to allow identification and retrieval of the EDSs and describe 
the characteristics of the EDS sample. Information about preparation of the EDS was 
collected to evaluate timeliness, by identifying whether the EDS was prepared and 
printed ready for issue at the point of discharge. Medicines-related information in the 
EDS was collected to list and describe the content and evaluate whether it was complete 
and accurate. Information about medication changes was collected to evaluate the 
construct validity of the medication changes note, based on whether it was complete and 
accurate. The inter-coder reliability of the medication changes notes was assessed by a 
second coder independently identifying if a medication changes note was entered on the 
EDS.  
 
The standardised document abstraction form, shown in Appendix 3, illustrates how the 
categories were operationalised. The form outlines the coding categories as well as the 
recording unit used and its source, with an explicit specification, in the form of coding 
instructions, of what indicators should be looked for in the EDS when making each of the 
categorisations. 
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2.10 Data collection 
 
Data were coded and input directly into the database in four stages. Firstly, data were 
collected to allow identification and retrieval of the EDS sample, as summarised in Table 
2.3. No patient demographic information was collected; the medical record number was 
recorded for the purpose of retrieving the EDS and ‘drug history note’ if the inclusion 
criteria were met. An example of a ‘drug history note’ on the JAC EPMA is shown in 
Appendix 1, Figures 10 and 11. 
 
Table 2.3: Data collected to aid selection of the EDS sample 
Data Source of data 
Medical record number Dispensing list printed from JAC 
Date dispensing list retrieved Dispensing list printed from JAC 
Date of admission JAC EPMA 
Date of discharge JAC EPMA 
Ward JAC EPMA 
Drug history note recorded JAC EPMA 
 
Secondly, data were collected from the EDS sample, as summarised in Table 2.4 (items 
shown in italics were obtained from pre-populated data fields of the EDS). An example of 
an EDS is shown in Appendix 2. 
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Table 2.4: Data collected from the EDS sample 
Preparation of the EDS Medicines-related information in the 
EDS 
Grade of doctor preparing the EDS Allergies information entered 
Consultant, coded  by division Is the ‘discharge medication’ complete and 
unambiguous? 
Letter status Number of TTA items prescribed 
Date EDS printed/revised Does the ‘discharge letter note’ contain 
information about inpatient medication? 
Have ‘discharge letter notes’ been entered 
by doctor?  
Does the ‘discharge letter note’ contain 
information about medication changes? 
Have ‘discharge letter notes’ been entered 
by pharmacist? 
Does the ‘discharge letter note’ contain 
information about medication 
recommendations? 
Have ‘discharge letter notes’ been entered 
by nurse? 
 
 
The third set of data collected was used to assess the construct validity of information 
about medication changes in the EDS, as summarised in Table 2.5. Two sources of data 
were compared; the TTA was reconciled with the ‘drug history note’ to evaluate the 
completeness and accuracy of information on medication changes in the EDS. Examples 
of an EDS and associated ‘drug history note’ used for reconciliation is shown in 
Appendix 2 and Appendix 1, Figure 11. 
 
The final set of data collected by two independent coders was used to assess the inter-
coder reliability of the information about medication changes, as summarised in Table 
2.5. 
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Table 2.5: Data collected for validity and reliability assessments of information 
about medication changes 
Construct validity Inter-coder reliability 
Have admission medications been stopped 
or changed? 
Does the ‘discharge letter note’ contain 
information about medication changes? 
Have new medications been started?  
Have all medication changes been listed?  
Have reasons for starting, stopping or 
changing medications been stated? 
 
Overall, is the information about 
medication changes complete and accurate? 
 
 
The database was checked for data integrity by sorting data and ensuring these were 
consistent with the coding instructions and there were no omissions or errors e.g. for all 
EDSs coded as prepared on day of discharge the date of discharge matched the date 
originally printed/revised.  
 
 
2.11 Pilot study 
 
A pilot study was carried out for a one week period in June 2010, to test the method of 
selecting EDSs for content analysis and the coding using the standardised document 
abstraction form shown in Appendix 3. This identified that, because of the extensive use 
of PODs and TTA pre-packs on some wards, many TTA requests did not result in a 
dispensing record. Therefore, TTA dispensing lists that were retrieved from the JAC 
system but did not require dispensing were also included during the EDS selection 
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process. In addition the standardised document abstraction form was also modified to 
reflect changes in category name, coding instruction and additional codes identified in the 
following categories: division; consultant by division; grade of doctor preparing the EDS; 
letter status; allergies and; discharge medication. The revised form is shown in Appendix 
4. 
 
 
2.12 JAC upgrade 
 
During the study, on 24
th
 July 2010, the JAC system was upgraded to version 4.47. The 
upgrade resulted in two new note types which contained medicines-related information; 
‘drugs patient admitted on which were modified during inpatient stay’ and ‘notes 
transferred from the inpatient chart’. The note type ‘drugs patient admitted on which were 
modified during inpatient stay’ was abbreviated to ‘drugs modified note’ for the purposes 
of the study. The note type ‘notes transferred from the inpatient chart’ was abbreviated to 
‘note to appear in EDS’ for the purposes of the study. In addition two wards, M10 and 
S6, were opened in August due to bed pressures and they were considered eligible for 
inclusion in the EDS sample. This made it necessary that a further revision be made to the 
data collection form during the study period, and the revised form is shown in Appendix 
5. Data was collected to indicate if the two new note types were present on the EDS or 
not, within the categories of ‘drugs modified note’ or ‘note to appear in EDS’. For EDSs 
printed prior to 24
th
 July data was entered retrospectively to indicate that the category was 
‘not applicable’.  
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2.13 Data analysis 
 
Descriptive statistics were used to summarise and describe patterns in data representing 
the medicines-related content of the EDS sample. Continuous variables such as length of 
stay and number of TTA items were described using the median and inter-quartile range, 
as the distribution of data values was positively skewed. Inter-coder reliability of the 
coding of medication changes notes was compared using the kappa statistic (Li Wan Po, 
1998; Robson, 2002). 
 
 
2.14 Ethics 
 
The Chair of the Isle of Wight, Portsmouth and South East Hampshire REC was of the 
opinion that ethical review was not required for this study, because it met the criteria for 
service evaluation. The study was given approval in June 2010 to proceed at WEHCT 
through the local clinical governance review and approval processes. 
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Section 3 Results 
 
3.1 The EDS sample 
The EDS sample comprised 1306 EDSs that met all the inclusion criteria, as shown in 
Figure 3.1. 656 (33%) of the 1962 EDSs that were eligible for inclusion were excluded 
due to no ‘drug history note’ being recorded on the JAC system for that unique episode of 
care.  
Figure 3.1: Selection of the EDS sample 
 
34 excluded - not 
discharged from JAC 
system by 1 September 
2 excluded – all TTAs 
deleted prior to discharge 
3 excluded - unable to 
retrieve JAC file 
The EDS sample 
1306 EDS with ‘drug 
history note’ on JAC 
 
656 excluded – no ‘drug 
history note’ on JAC 
1962 EDS, including TTA, 
for patients discharged 
from an included ward 
during July and August 
2010 
 
2001 potential EDS from 
included wards identified 
from dispensary records 
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3.1.1 Characteristics of the excluded EDSs 
Data collected from the EDSs comprised pre-populated data including ward, date of 
admission and date of discharge. 
 
3.1.1.1 Ward by division 
Two wards were opened in August, M10 (M&E division) and S6 (S&A division), and 
EDSs from these wards were considered eligible for inclusion in the EDS sample. The 
proportion of excluded and included EDSs were compared by ward and division to 
identify trends, as shown in Figure 3.2. 
 
Figure 3.2: Comparison of excluded and included EDSs by ward and division 
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Prior to applying the ‘drug history note’ exclusion criterion, the S&A division accounted 
for the largest proportion of the EDSs; after exclusion, the M&E division accounted for 
the largest proportion of the EDSs. Exclusion of EDSs that had no ‘drug history note’ 
resulted in 59% of the EDS sample representing the FS division, 43% of the S&A 
division, and 18% of the M&E division being excluded. 
 
S4, M3 and F1 represented the top three wards, by number of EDSs prior to applying the 
‘drug history note’ exclusion criterion. Exclusion of EDSs that had no ‘drug history note’ 
resulted in the majority of EDSs from S4, M3 and F1 being excluded; together 
comprising 88% of the excluded EDSs.  
 
3.1.1.2 Length of stay 
The length of stay was calculated from the admission and discharge dates associated with 
the episode of care that resulted in the EDS. Any part or whole day was counted as one 
day e.g. a day case was counted as one day, an overnight stay as two days. Data are 
shown in Figure 3.3 and Table 3.1. 
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Figure 3.3: Comparison of excluded and included EDSs by length of stay (n=1962) 
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Table 3.1: Comparison of excluded and included EDSs by median and inter-quartile 
range of length of stay 
 Lower quartile 
(Q1) 
Median (Q2) Upper quartile 
(Q3) 
All EDSs 
(n=1962) 
2 days 4 days 8 days 
Included EDSs 
(n=1306) 
4 days 7 days 12 days 
Excluded EDSs 
(n=656) 
1 day 2 days 3 days 
 
The excluded EDSs were characterised by a shorter length of stay and the absence of a 
‘drug history note’ recorded on the JAC. The EDS sample was characterised by a longer 
length of stay and the recording of a ‘drug history note’ on the JAC. 
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3.1.2 Characteristics of the EDS sample 
Data collected from the EDS sample comprised pre-populated data including ward, date 
of admission and date of discharge. 
 
3.1.2.1 Ward by division 
The ward name entered on the EDS was grouped by division. The data are summarised in 
Figure 3.4. 
 
Figure 3.4: Proportion of the EDS sample by ward and division (n=1306) 
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All three divisions were represented in the EDS sample; the largest proportion was from 
M&E division (55%), followed by S&A (39%) and FS (6%). S3, M1 and S2 ward 
represented the top three wards by number of EDSs. S6, M10 and S4 ward represented 
the smallest proportion of the EDSs. 
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3.1.2.2 Length of stay 
The length of stay was calculated from the admission and discharge dates associated with 
the episode of care that resulted in the EDS. Data are shown in Figure 3.5 and Table 3.2. 
 
Figure 3.5: Comparison of the EDS sample by division and length of stay (n=1306) 
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Table 3.2: Comparison of the EDS sample by division and median and inter-quartile 
range of length of stay 
Length of stay Lower quartile 
(Q1) 
Median (Q2) Upper quartile 
(Q3) 
EDS sample 
(n=1306) 
4 days 7 days 12 days 
M&E division 
(n=713) 
4 days 8 days 15 days 
S&A division 
(n=510) 
4 days 6 days 9 days 
FS division 
(n=83) 
2 days 4 days 6 days 
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The EDS sample representing the FS division was characterised by a shorter length of 
stay. The EDS sample representing the M&E division was characterised by a longer 
length of stay. 
 
3.1.2.3 Month of discharge 
The month of discharge was coded from the date of discharge. The EDS sample was 
compared by division and month of discharge. Data are shown in Figure 3.6. 
 
Figure 3.6: Comparison of the EDS sample by division and month of discharge 
(n=1306) 
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The EDS sample was characterised by more discharges in July (54%) than August (46%). 
The reduced number of discharges in August was a result of fewer discharges from the 
S&A and FS divisions; the discharges from the M&E division were unchanged. 
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3.1.2.4 Day of discharge 
The day of discharge was coded from the date of discharge. Data are shown in Figure 3.7. 
 
Figure 3.7: Comparison of the EDS sample by division and day of discharge 
(n=1306) 
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The highest proportion of discharges was, in descending order, on Friday, Thursday and 
Tuesday. The lowest proportion of discharges was on Sunday and Saturday. Discharges 
from M&E and FS divisions were most frequent on Fridays; discharges from S&A 
division were most frequent on Thursdays. 
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3.2 Preparation of the EDSs 
Data collected from the EDS sample comprised pre-populated data including consultant, 
doctor preparing the EDS, completion status of the EDS, and date of completion; and 
manually entered data in the form of ‘discharge letter notes’. 
 
3.2.1 Consultant 
The consultant name entered on the EDS was coded by division. The frequency with 
which each division occurred when coded by consultant differed from that identified 
when coding by ward. The two sets of data were compared to identify the scale and type 
of differences that emerged in coding the division by ward and by consultant. The data 
are summarised in Figure 3.8. 
 
Figure 3.8: Comparison of division coding by ward and consultant (n=1306) 
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Comparing the coding of division by consultant and by ward showed that the consultant 
teams did not only use wards allocated to their division. M&E consultant teams had the 
majority of cases on M&E wards (92%), but also had 57 (7%) on S&A wards and five 
(1%) on a FS ward. S&A consultant teams had the majority of cases on S&A wards 
(92%), but also had ten (2%) on M&E wards and 29 (6%) on a FS ward. FS consultant 
teams had the majority of cases on the FS ward (98%) and one (2%) on a S&A ward. The 
coding of division by consultant team was judged to be a more accurate indicator than 
division by ward, and thus was subsequently used as the comparator by division (unless 
otherwise indicated). 
 
3.2.2 Doctor preparing the EDS 
The electronic signature of the doctor preparing the EDS was coded by grade and 
division. The doctor code was compared with the division by consultant team to identify 
any discrepancies. The data are summarised in Table 3.3. 
 
The majority of the EDSs were prepared by house officers in the M&E and S&A 
divisions (67% of EDS sample), followed by senior house officers from all three 
divisions (30% of EDS sample). Comparison of the doctor preparing the EDS and the 
division by consultant team showed that the doctor was not always from the same 
division as the consultant team. In 21 cases S&A doctors prepared EDSs attributed to 
M&E consultants, in one case a S&A doctor prepared an EDS attributed to a FS 
consultant, in three cases FS doctors prepared EDSs attributed to S&A consultants, and in 
eight cases M&E doctors prepared EDSs attributed to S&A consultants. 
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Table 3.3: Comparison of doctor preparing the EDSs by division (n=1306) 
Division by consultant 
team 
 
Doctor preparing the 
EDS 
 
Total 
 
M&E 
M&E house officer 
(F1M&E) 474 
  
M&E senior house officer 
(F2M&E) 244 
  M&E registrar (RegM&E) 23 
  
M&E consultant 
(ConM&E) 3 
  
S&A house officer 
(F1S&A) 18 
  
S&A senior house officer 
(F2S&A) 1 
  S&A registrar (RegS&A) 2 
M&E Total   765 
S&A 
M&E house officer 
(F1M&E) 3 
  
M&E senior house officer 
(F2M&E) 5 
  
S&A house officer 
(F1S&A) 381 
  
S&A senior house officer 
(F2S&A) 86 
  S&A registrar (RegS&A) 12 
  S&A consultant (ConS&A) 1 
  
FS senior house officer 
(F2FS) 3 
S&A Total   491 
FS 
S&A house officer 
(F1S&A) 1 
  
FS senior house officer 
(F2FS) 49 
FS Total   50 
 
 
3.2.3 Status of the EDSs at discharge 
The status of the EDS was coded by whether it was completed and printed or provisional 
at the point of discharge. The data are summarised in Figure 3.9. 
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Figure 3.9: Proportion of the EDS sample by status at discharge (n=1306) 
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A ‘complete’ EDS was an EDS that had been completed and printed; a revised EDS was 
a ‘complete’ EDS that had been revised and reprinted.  97% of the EDS sample was 
‘complete’ and printed/reprinted at discharge; 46% of the EDS sample had been revised 
after completion and reprinted. 45 (3%) EDSs were not printed prior to discharge, 
comprising both provisional and ‘complete’ EDSs, of these 13 were printed post-
discharge and five were provisional. A provisional EDS was an EDS that had been 
prepared but not completed and printed. The EDSs were more frequently revised in M&E 
division and more frequently ‘complete’ in S&A division. 
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3.2.4 Preparation of the EDSs prior to discharge  
Preparation of the EDS prior to discharge was coded by comparing the date of discharge 
with the date the EDS was completed or revised e.g. if the dates were the same it was 
coded as ‘day of discharge’. The data are summarised in Table 3.4. 
 
Table 3.4: Proportion of the EDS sample by preparation of EDSs (n=1306) 
Preparation of EDS Total 
 
Percentage 
Day of discharge 831 65 
Day before discharge 254 19 
Three or more days before 
discharge 105 
 
8 
Two days before discharge  71 5 
N/A – not printed 32 2 
Post-discharge reprint 13 1 
 
The largest proportion (65%) of the EDSs were completed or revised on the day of 
discharge; and this occurred in all three divisions. 32% were completed or revised one 
day or more before discharge, and 1% were printed after discharge. 32 (2%) EDSs were 
never printed, and this occurred most frequently on ward F1. 
 
3.2.5 Discharge letter notes 
‘Discharge letter notes’ added to the EDS took the form of doctor letter notes, pharmacist 
letter notes, and nurse letter notes. The ‘discharge letter notes’ were compared to identify 
the scale and types of differences. The data are summarised in Tables 3.5 and 3.6 and 
Figures 3.10 and 3.11. 
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Table 3.5: Proportion of the EDS sample by type of ‘discharge letter note’ (n=1306) 
 
Doctor letter notes 
 
Pharmacist letter 
notes 
Nurse letter notes 
 
Division by 
consultant team No Yes No Yes No Yes 
M&E 72 693 698 67 761 4 
S&A 24 467 481 10 480 11 
FS 8 42 50 0 50 0 
Total 104 1202 1229 77 1291 15 
 
The most frequent ‘discharge letter notes’ were written by a doctor (92% of the EDS 
sample). Doctor letter notes were entered by a JAC user identified by the system as a 
doctor. The second most frequent ‘discharge letter notes’ were written by a pharmacist 
(6% of the EDS sample). Pharmacist letter notes were entered by a JAC user recognised 
by the system as a pharmacist. The least frequent ‘discharge letter notes’ were written by 
a nurse (1% of EDS sample). Nurse letter notes were entered by a JAC user recognised 
by the system as a nurse. 
 
Table 3.6: Comparison of the types of ‘discharge letter notes’ in the EDSs (n=1306) 
Doctor letter 
notes 
 
Pharmacist letter 
notes 
 
Nurse letter 
notes 
 Total 
No No No 82 
  Yes 5 
 Yes No 17 
Yes No No 1132 
  Yes 10 
 Yes No 60 
 
In 82 (6%) of the EDSs, no ‘discharge letter notes’ were entered. Where no ‘discharge 
letter notes’ were entered the data were compared by division and more frequently 
occurred in the FS division followed by the M&E and S&A divisions. In 1132 (87%) a 
doctor letter note was the only ‘discharge letter note’ entered. In 17 (1%) of the EDSs a 
 87 
pharmacist letter note was the only ‘discharge letter note’ entered. In five of the EDSs a 
nurse letter note was the only ‘discharge letter note’ entered. 
 
Figure 3.10: Doctor letter notes by ward and division (n=1202) 
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A doctor letter note was more frequently written on the S&A division EDSs (95%) than 
the M&E division EDSs (91%) or FS division EDSs (84%). A pharmacist letter note was 
more frequently written on a M&E division EDS (9%) than a S&A division EDS (2%). 
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Figure 3.11: Pharmacist letter notes by ward and division (n=77) 
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3.3 Medicines-related information in the EDS 
Data collected from the EDSs comprised pre-populated data including allergies and 
discharge medications; and manually entered data coded as inpatient medication notes, 
medication changes notes and medication recommendations notes. 
 
3.3.1 Allergies 
The allergies information on the EDSs was coded by whether data were entered or not; 
and by category where entered. The data are summarised in Table 3.7 and Figure 3.12. 
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Table 3.7: Comparison of allergies data by division (n=1306) 
 
Division by consultant team 
  
 
Allergies M&E S&A FS Total Percentage 
No known drug 
allergies (NKDA) 442 291 33 766 59 
drug allergy 286 156 14 456 35 
absent data 23 32 2 57 4 
non-drug allergy 11 12 1 24 2 
undetermined 3 0 0 3 0.2 
 
Allergies data was absent in 4% of the EDSs. The highest frequency of absent data was in 
the S&A division (7% of S&A EDSs), followed by FS (4% of FS EDSs) and M&E (3% 
of M&E EDSs) divisions. 
 
Figure 3.12: Categories of allergies data in the EDSs, where entered (n=1249) 
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The most frequent category of allergies data entered was NKDA (61%), followed by drug 
allergy to a named drug (37%). 
 
3.3.2 Discharge medications  
Data were collected on the number of discharge medications (TTAs) entered on the EDS, 
and their completeness. 
 
3.3.2.1 Number of TTA items 
The numbers of TTA items on the ‘discharge medication’ list was obtained from the 
EDSs. The data are summarised in Figure 3.13 and Table 3.8.  
 
Figure 3.13: Comparison of number of TTA items by division (n=1306) 
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Table 3.8: Comparison of EDS sample by median and inter-quartile range of 
number of TTA items by division 
 Lower quartile 
(Q1) 
Median (Q2) Upper quartile 
(Q3) 
EDS sample 
(n=1306) 
3 items 6 items 9 items 
M&E division 
(n=765) 
4 items 7 items 10 items 
S&A division 
(n=491) 
3 items 5 items 8 items 
FS division 
(n=50) 
2 items 3 items 5 items 
 
The EDSs representing the FS division were characterised by fewer TTA items. The 
EDSs representing the M&E division were characterised by a greater number of TTA 
items. 
 
3.3.2.2 Completeness of discharge medications in EDS 
The discharge medications in the EDSs were coded to indicate if they were complete or 
were incomplete, or contained duplicates or discrepancies. The data were compared by 
division and are summarised in Figure 3.14. 
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Figure 3.14: Comparison of completeness of discharge medications by division 
(n=1306) 
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89% of the EDSs were complete and had no missing data, prescribing discrepancies or 
duplicate TTAs. Duplicate TTAs (8%) was the most frequent discharge medication 
anomaly, followed by prescribing discrepancies (3%) and incomplete/missing data (1%). 
 
3.3.2.3 Medication notes in the EDS 
Notes about medications in the EDS were coded according to whether they were notes 
about the inpatient medication treatment, notes about medication changes or medication 
recommendations made to the GP or patient. The medication notes were compared to 
identify the scale and types of differences. The data are summarised in Tables 3.9 and 
3.10. 
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Table 3.9: Proportion of the EDS sample by type of medication note (n=1306) 
 
Medication changes 
note 
Inpatient medication 
note 
Medication 
recommendations 
note 
Division by 
consultant team No Yes No Yes No Yes 
FS 33 17 43 7 47 3 
M&E 225 540 422 343 600 165 
S&A 199 292 358 133 444 47 
Total 457 849 823 483 1091 215 
 
The most frequent medication notes written were medication changes notes (65% of EDS 
sample), followed by inpatient medication notes (37% of EDS sample) and medication 
recommendations notes (16% of EDS sample). More than one type of note may be 
present in the EDS. 
 
Table 3.10: Comparison of the types of medication note in the EDSs (n=1306) 
Medication changes 
note 
Inpatient medication 
notes 
Medication recommendations 
note Total 
No No No 358 
   Yes 8 
  No Total  366 
  Yes No 86 
   Yes 5 
  Yes Total  91 
No Total   457 
Yes No No 339 
   Yes 118 
  No Total  457 
  Yes No 308 
   Yes 84 
  Yes Total  392 
Yes Total   849 
 
In 358 (27%) of the EDSs no medication notes were entered. The most frequently 
occurring combination of medication notes was medication changes note only (26% of 
the EDS sample), followed by medication changes note in combination with inpatient 
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medication note (24%) and medication changes note in combination with medication 
recommendations note (9%). 
 
3.3.2.4 Additional notes 
Two new types of notes from 24 July appeared in the EDSs: ‘drugs modified note’; and 
‘note to appear in EDS’. Data are shown in Figure 3.15. 
 
Figure 3.15: ‘Drugs modified note’ by ward and division (n=61) 
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The ‘drugs modified note’ appeared in 61 EDSs, most frequently the S&A division 
(55%), followed by M&E (42%) and FS (3%). Ward S3 a surgical and orthopaedic ward 
accounted for 31% of all ‘drugs modified notes’. The ‘note to appear in EDS’ occurred 
only nine times within the study period; four in the M&E and S&A divisions, and one in 
the FS division. 
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3.4 Medication changes 
10% of the EDS sample was selected to assess the construct validity of the medication 
changes notes documented in the EDSs. The sample comprised 138 EDSs, randomly 
selected and stratified to ensure proportionate sampling by ward. The number and type of 
medication changes, identified by comparing the EDSs with the ‘drug history notes’, are 
shown in Table 3.11. 
 
Table 3.11: Number and type of medication changes between the EDSs and drug 
history notes (n=138) 
 
New medications started? 
  
 
Admission medications stopped or 
changed? No Yes Total Percentage 
No 6 50 56 41 
Yes 12 70 82 59 
Total 18 120 138  
Percentage 13 87  100 
 
New medications were started (87%) more frequently than admission medications were 
stopped or changed (59%). Six (4%) EDSs had no medication changes of any type; and 
70 (51%) EDSs had medication changes of both types. The 132 (96%) EDSs that were 
associated with medication changes of any type were reviewed for the presence of 
information about medication changes. The data are summarised in Tables 3.12 and 3.13. 
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Table 3.12: Medication changes information in the EDSs associated with new 
medications started (n=120) 
 
New medications started 
     
Medication additions 
listed? 
Reason for medication additions 
stated? Total Percentage 
Incomplete Incomplete 2 2 
  No 7 6 
  Yes 35 29 
Incomplete Total   44  
No No 49 41 
No Total   49  
Yes Yes 27 22 
Yes Total   27  
 
There were 120 EDSs where new medications were started; in 49 (41%) of the EDSs 
there was no information about the new medications, in 27 (22%) there was complete 
information about the new medications, and in the remaining 44 EDSs the information 
was incomplete (37%). 
 
Table 3.13: Medication changes information in the EDSs associated with admission 
medications stopped or changed (n=82) 
 
Admission medications stopped or changed 
     
Admission medication 
changes listed? 
Reason for medication changes 
stated? Total Percentage 
Incomplete No 4 5 
  Yes 14 17 
Incomplete Total   18  
No No 49 60 
No Total   49  
Yes No 2 2 
  Yes 13 16 
Yes Total   15  
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There were 82 EDSs where admission medications were stopped or changed; in 49 (60%) 
of the EDSs there was no information about changes to the admission medications, in 13 
(16%) there was complete information about changes to the admission medications, and 
in the remaining 20 EDSs the information was incomplete (24%). Information about 
changes to admission medications, whether incomplete or complete, occurred less 
frequently than information about new medications started. 
 
Table 3.14: Comparison of coding of medication changes note and completeness of 
note (n=138) 
 
Medication changes 
note  
 
Completeness of medication 
changes note No Yes Total Percentage 
Incomplete 1 69 70 51 
No 38 6 44 32 
Yes 0 18 18 13 
No medication changes  4 2 6 4 
Total 43 95 138  
Percentage 31 69  100 
 
In 44 (32%) of the EDSs there was no information about changes to medications; six of 
the EDSs had previously been coded as having a medication changes note, but the note 
was a ‘drugs modified note’ that was misleading. In 18 (13%) there was complete 
information about changes to medications, and in 70 (51%) the information was 
incomplete. The remaining six (4%) EDSs had no medication changes; two of the EDSs 
had previously been coded as having a medication changes note, but the note was a 
‘drugs modified note’ that was misleading. 
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3.5 Inter-coder reliability of medication changes coding 
A random sample of 30 EDSs was independently coded for information about medication 
changes. The kappa statistic was calculated to measure inter-coder variability i.e. how 
often the two coders agree on their interpretations, as shown on Table 3.15. 
 
Table 3.15: Inter-coder variability 
 Coder 1  
Coder 2 Yes No Totals 
Yes 15 0 15 
No 4 11 15 
Totals 19 11 30 
 
Kappa = 0.733 
Proportion agreement = 0.86 
Bias index = -0.13 
Prevalence index = 0.13 
 
The kappa statistic of 0.733 indicates a good strength of agreement between the two 
coders (Robson, 2002). 
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Section 4 Discussion 
 
4.1 The EDS sample 
 
The EDS sample comprised 1306 discharges from the included wards between 1
st
 July 
and 31
st
 August 2010. TTAs were prescribed on all EDSs and a ‘drug history note’ was 
recorded on the JAC system. All three divisions and included wards at WEHCT were 
represented in the EDS sample; the largest proportion was from wards in the M&E 
division, followed by the S&A and FS divisions. Two temporary wards were opened in 
August and these were considered eligible for inclusion in the EDS sample. 
 
The length of stay of the episode of care associated with the EDSs varied depending on 
the division the patient was discharged from. The FS division had the shortest length of 
stay (median four days), followed by the S&A division (median six days); and the M&E 
division had the longest stay (median eight days). These findings were consistent with the 
ward speciality; S&A and FS wards take surgical patients that tend to have shorter stays, 
and M&E wards take medical patients that tend to have longer stays in hospital 
particularly when associated with elderly care and rehabilitation. Therefore, these 
findings add construct validity to the study. 
 
The EDS sample was characterised by more patient discharges in July than August. The 
reduced number of discharges in August was the consequence of fewer discharges from 
the S&A and FS divisions; the frequency of discharges from the M&E division was 
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unchanged. The August bank holiday may have been a contributing factor, as there would 
have been fewer admissions for day surgery and consequently fewer discharges. 
 
WEHCT aims to achieve seven day a week discharges, and the results demonstrate that 
this was achieved (WEHCT, 2009). However, patients were most frequently discharged 
on weekdays, most often Friday, and less frequently at the weekend. The M&E and FS 
divisions most frequently discharged patients on Friday and the S&A division on 
Thursday, which would release acute beds for emergency admissions over the weekend. 
 
 
4.1.1 The effect of exclusion criteria on the EDS sample 
 
656 (33%) EDSs were excluded from 1962 eligible EDSs, due to no ‘drug history note’ 
being recorded on the JAC system. Most of the EDSs excluded were from S4, M3 and 
F1, and combined, accounted for 88% of the excluded EDSs. In particular, S4 which had 
the highest proportion of eligible EDSs, had the lowest proportion of the EDS sample 
after the exclusion criterion was applied (if M10 and S6, which opened temporarily in 
August, were overlooked).  
 
Prior to exclusion of EDSs with no ‘drug history note’, the S&A division had the largest 
proportion of the EDSs, after exclusion the M&E division had the largest proportion of 
the EDS sample. This resulted from only 18% of the M&E division EDSs being 
 101 
excluded, as opposed to 59% of the FS division EDSs and 43% of the S&A division 
EDSs.  
 
The high exclusion rate from wards S4, M3 and F1 can be explained by considering the 
process of the ‘drug history note’ getting entered onto the JAC system. The ‘drug history 
note’ was entered on the JAC system by the Medicines Management technicians, or by 
the ward pharmacist where there was no technician service. S4 and M3 did not have a 
Medicines Management technician service, and in addition S4 did not have a pharmacist 
visiting service. Therefore, it was predictable that a lot of the EDSs from M3 should be 
excluded, as there was no technician service. What was surprising was that any S4 EDSs 
should be included; it was possible that these EDSs were associated with ‘drug history 
notes’ entered on another ward prior to the patient being transferred to S4. Transferring 
patients in this manner may be done to release acute beds, and would be consistent with 
the need to open extra wards in August. Wards M10 and S6 that were opened in August 
also did not have a Medicine Management technician or routine pharmacist visiting 
service, so based on the above reasoning would be expected to have a high rate of 
exclusions. However, this did not occur as these wards were being used as discharge 
wards i.e. a location to place patients from other wards that were fit for discharge and 
awaiting transport; thus they had ‘drug history notes’ entered on another ward that did 
have a technician service.  
 
The length of stay of the excluded EDSs (median two days, inter-quartile range one to 
three days) was much shorter than the EDSs sample (median seven days, inter-quartile 
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range four to 12 days). These findings were consistent with the ward speciality of S4 and 
F1, which have a lot of surgical day cases and short stays; and M3 which was a medical 
admissions ward with a maximum stay of three days. The short length of stay would also 
have contributed to the lack of a ‘drug history note’, as it increased the likelihood that the 
patient would be discharged before the drug history could be taken or recorded on JAC. 
This may explain the high exclusion rate from F1 which did have a Medicines 
Management technician and ward pharmacist. 
 
The EDSs of patients that were day cases or overnight stays were disproportionately 
excluded, and were under-represented in the EDS sample. Consequently the EDS sample 
under-represents the S&A and FS divisions, due to the high proportion excluded. The 
methodology introduced potential bias towards EDSs from the M&E division by 
excluding all EDSs with no associated ‘drug history note’.  
 
 
4.2 Preparation of the EDSs 
 
All EDSs were prepared prior to discharge and were available for content analysis. An 
EDS was always available, as the prescribing of TTAs automatically generated an EDS; 
the JAC system only generates a TTA dispensing list in pharmacy when the EDS is 
‘complete’. After the patient has been discharged from the JAC system an EDS cannot be 
prepared and TTAs cannot be prescribed. Therefore, the process of prescribing TTAs on 
the JAC system ensured that EDSs were prepared prior to discharge. Research has shown 
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that delays in GPs receiving information was a major patient safety risk, and many 
discharge summaries were prepared after the patient was discharged or not at all 
(Mageean, 1986; Penney, 1988). The process at WEHCT ensured that an EDS was 
prepared prior to discharge but did not ensure it was completed or printed, as this part of 
the process may not be performed. Forty five (3%) of the EDSs were not printed prior to 
discharge; comprising both provisional and ‘complete’ EDSs. A provisional EDS was an 
EDS that had been prepared but not completed and printed. The majority (97%) of the 
EDS sample was ‘complete’ and printed at discharge, and 46% had been revised after 
completion and reprinted. Data may be entered into the EDS throughout the episode of 
care. When preparing the EDS, the doctor can choose to ‘complete’ and print the EDS 
when they have finished entering information, or leave it in a provisional status, as shown 
in Appendix 1, Figures 15 and 16. Either way they can access the EDS on another 
occasion and revise it (if already completed) or ‘complete’ it (if provisional). 
 
Five EDSs were provisional, which meant that the TTAs prescribed were not requested 
from pharmacy via the JAC system, the EDSs were not printed, and the patients and GPs 
did not receive a copy of the EDSs. This was a patient safety risk because TTAs were not 
requested, clinically screened by the pharmacist, or dispensed for discharge. Thus, 
patients may not have been supplied with medicines that they required for discharge or a 
copy of the EDS; in addition a copy of the EDS was not filed in the patient’s notes or 
posted to the GP. What was not known was how many EDSs were provisional when 
patients were discharged from the JAC system. A provisional EDS would not be expected 
to occur in this study, as the study design would preclude its selection; a provisional EDS 
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does not generate a TTA dispensing list via JAC. It may be concluded that the five 
provisional EDSs in the EDS sample arose because the omission had been recognised and 
a TTA dispensing record was generated outside of the normal process e.g. TTAs 
requested by ward staff and the provisional letter manually printed from JAC by 
dispensary staff to generate a request against which to dispense the TTAs.  
 
Forty EDSs were completed but not printed prior to discharge, which meant that the 
patient did not receive a copy of the EDS and a copy was not filed in the patient’s notes. 
The GP may not have received any information about the patient’s stay in hospital via the 
EDS; this was not an absolute outcome, because one advantage of the electronic system 
was that when a patient was discharged a copy of the EDS was sent electronically to the 
majority of local GP surgeries that requested that service. This situation, if recognised as 
an omission, may be in part mitigated by a post-discharge reprint being obtained from the 
JAC system; and this was shown to occur for 13 of the EDSs. 
 
The largest proportion, 65% of the EDSs, were completed or revised on the day of 
discharge, 32% were completed or revised one day or more before discharge, 2% were 
never printed, and 1% were printed after discharge. This may indicate either a quick 
turnaround of EDSs once a decision was made to discharge a patient, or that preparation 
of the EDSs occurred throughout the episode of care with many completed EDSs being 
revised prior to discharge; including on the day of discharge, ensuring that information in 
the EDSs was up-to-date. Discharge can be considered a process and not an isolated 
event; it has to be planned for at the earliest opportunity between the primary, hospital 
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and social care organisations, ensuring that patients and their carer(s) understand and are 
able to contribute to care planning decisions as appropriate (DOH, 2005). There may be a 
risk associated with the practice of revising the EDS; if there are multiple printouts of the 
EDS care needs to be taken to ensure the obsolete versions are destroyed. This may in 
part explain why some prescribers choose not to print the letter; if they intended to go 
back and change the EDS later and failed to do so. An improvement could be the 
automatic printing of the EDS as the patient was discharged from JAC, with an electronic 
copy sent to the GP simultaneously. 
 
The EDS must be written prior to the time of discharge to be able to achieve the NHS 
Standard Contract requirements for hospitals; that each patient receives a discharge 
summary at the time of discharge, and a discharge summary is issued to the patient’s GP 
within 24 hours of discharge. The use of EDSs at WEHCT enables the efficient and 
timely generation of discharge summaries, 97% were prepared and printed prior to the 
time of discharge, which is an advantage in achieving this standard. This was in contrast 
to the NHS Hampshire (2010) survey findings that discharge summaries were timely in 
51% of cases. Disparity between these figures can be explained, as the survey recorded 
receipt of discharge summaries at the GP surgery, and did not define timeliness. This 
study measured if they were ready at the point of discharge, not that they were received 
by the GP surgery. Previous published studies have shown that EDSs improved the 
timeliness of discharge summaries, but either did not define how timeliness was 
measured or the standard was within two weeks (O’Leary et al., 2009; Alderton & Callen, 
2007). 
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4.2.1 Consultant name 
 
The consultant name that appeared on the EDS was coded by division. Comparison of the 
coding of division by consultant and by ward showed that the frequency of the divisions 
differed. M&E consultants had the majority of their patients on M&E wards (92%), but 
also had patients on S&A and FS wards. S&A consultants had the majority of their 
patients on S&A wards (92%), but also had patients on M&E and FS wards. FS 
consultants had the majority of their patients on the FS ward (98%) and one case on a 
S&A ward. The reason for this discrepancy could be one of three reasons: the consultant 
team could be using beds on another division’s ward e.g. surgical teams using FS beds 
for day surgery; the transfer of patients from ward to ward to release acute beds e.g. a 
medical outlier on a surgical ward; or an incorrect record of consultant on the JAC system 
e.g. a patient admitted under a S&A consultant, transferred to a M&E consultant for 
rehabilitation but the JAC data were not updated.  
 
To explain this discrepancy one has to understand where the data on the EDSs came 
from. The ward data field on the EDS was pre-populated with information from the JAC 
system, and indicated the ward the patient was located on, at the point of discharge from 
the system. This ward was not necessarily the ward where the patient spent most of their 
hospital stay or where the consultant team was based, as patients may be moved from 
ward to ward. The consultant name data field on the EDS was pre-populated with 
information from the JAC system and indicated the consultant the patient was under the 
care of at the point of discharge from the system. Patients may be transferred between 
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consultant teams during their hospital stay e.g. patients may be admitted under an 
emergency department consultant for initial assessment and then transferred to the care of 
the most appropriate speciality consultant team. Both of these data fields have to be 
updated when this occurs, and this automatically happens on the JAC system when the 
patient is transferred on the CERNER patient administration system. There are exceptions 
to this process if the patient has been ‘manually admitted’ to JAC; then the data fields are 
not automatically updated and it has to be carried out manually. Therefore, there remains 
the possibility that the consultant and ward are not updated; in practice the ward data will 
get updated manually, as drug administrations cannot be accessed on the new ward 
otherwise, but the wrong consultant name does not affect the functionality of the JAC 
system and is more likely to be overlooked. There is a risk of bias due to this discrepancy. 
The coding of division by consultant team was judged to be a more accurate indicator 
than division by ward, and thus was used as the comparator. 
 
 
4.2.2 Doctor preparing the EDS 
 
The majority of EDSs were prepared by house officers in the M&E and S&A divisions 
(67%), and almost exclusively by senior house officers in the FS division. Most M&E 
EDSs were prepared by M&E house officers, and completed or revised on the day of 
discharge. Most S&A EDSs were prepared by S&A house officers, and completed or 
revised on the day of discharge. The majority of EDSs (97%) were prepared by junior 
doctors, which is consistent with other studies investigating the grade of doctor preparing 
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the discharge summary (Frain et al., 1987; Macaulay et al., 1996), and adds construct 
validity to the study. These grades of staff have been associated with the highest 
prevalence of medication errors (Dornan et al., 2009), and junior doctors have been 
shown to make more errors in surgical discharge summaries than registrars or consultants 
(Macaulay et al., 1996). 
 
Given the discrepancy identified between the coding of division by ward and by 
consultant, the division of the doctor preparing the EDS was compared with the division 
by consultant team.  This showed that the doctor who prepared the EDS was not always 
from the same division as the consultant team. A total of 33 discrepancies were 
identified: in 21 cases S&A doctors prepared EDSs attributed to M&E consultants; in one 
case a S&A doctor prepared an EDS attributed to a FS consultant; in three cases FS 
doctors prepared EDSs attributed to S&A consultants; and in eight cases M&E doctors 
prepared EDSs attributed to S&A consultants. It was highly likely that the consultant 
name was incorrect in these 33 EDSs, given the possibility that the consultant name may 
not always be automatically updated. The name of the doctor preparing the EDS was pre-
populated from the JAC system, which recognised the electronic signature of the JAC 
user (which is a function of the user name and password) and entered their name on the 
EDS. What was not known was how many wrong consultant names from the same 
division occurred, as this was outside the scope of the study; this may warrant further 
investigation as it seems likely that the incorrect consultant name may sometimes be pre-
populated onto the EDS. This introduced a risk of bias when comparing results by 
division, but on balance, as the number suspected of miscoding was the smaller 
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proportion, the consultant team was judged to be a more accurate indicator of the division 
than ward and was used as the comparator for analysis of data. However, it was 
acknowledged that, although reduced, there remained a risk of bias due to the suspected 
miscoding of the consultant team.  
 
 
4.2.3 ‘Discharge letter notes’ in the EDS 
 
‘Discharge letter notes’ were written for 94% of the EDS sample, and took the form of 
doctor letter notes, pharmacist letter notes, and nurse letter notes; these notes were 
specific to the JAC user e.g. a pharmacist can only enter a pharmacist letter note. The 
most frequent ‘discharge letter notes’ were written by a doctor (92% of the EDS sample). 
A doctor letter note was more frequently written on the S&A division EDSs (95%) than 
the M&E division EDSs (91%) or FS division EDSs (84%). The other types of note were 
entered less frequently; ‘discharge letter notes’ were written by a pharmacist for 6% of 
the EDS sample, and by a nurse for 1%. Clearly, doctors were the main users of this 
function, with pharmacists and nurses occasionally making entries in addition to the 
doctor. In 17 (1%) of the EDSs a pharmacist letter note was the only note entered; and in 
five of the EDSs a nurse letter note was the only note added. Nurse letter notes were more 
frequently written on the S&A division EDSs than M&E. Pharmacist letter notes were 
more frequently written on the M&E division EDSs (9%) than S&A (2%), and all these 
notes contained information about medication changes and/or medication 
recommendations. The distribution of doctor letter notes and pharmacist letter notes were 
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different, there were more doctor letter notes in surgery but more pharmacist letter notes 
in medicine, which may be influenced by pharmacist staffing levels in each division. 
These findings are consistent with the divisional speciality; the M&E division has more 
speciality pharmacists, who work closely with the consultant teams, than the other 
divisions. Therefore, these findings add construct validity to the study. 
 
In 82 (6%) of the EDSs no ‘discharge letter notes’ were entered. Where no ‘discharge 
letter notes’ were written, this represented 16% of the FS division EDSs, 9% of the M&E 
division EDSs, and 5% of the S&A division EDSs. Ward M6 had the most EDSs without 
‘discharge letter notes’; it was also the ward with the highest frequency of a pharmacist 
note being written. M6 was a care of the elderly ward and one would expect that there 
was both time and opportunity to write ‘discharge letter notes’; so the absence of notes 
was counterintuitive. This situation, if recognised as an omission, may in part be 
mitigated by a discharge summary being produced post-discharge on the CERNER 
patient administration system, which has a discharge summary functionality. The TTA 
prescribed on JAC does not pre-populate to the CERNER discharge summary, and thus 
there is a risk inherent in a process that requires the transcribing of TTA information from 
one system to another (Callen et al., 2010). It appears that the speciality pharmacist may 
be identifying and correcting an omission of medicines-related information in the EDSs 
prior to discharge by writing pharmacist letter notes. 
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4.3 Medicines-related information in the EDSs 
 
4.3.1 Medication notes in the EDSs 
 
The ‘discharge letter notes’ section of the EDSs was not pre-populated with data; 
information had to be entered in free text, and it could contain information relating to any 
aspect of the patients admission history and examination, diagnosis and treatment, 
nursing care, medicines management, or post-discharge follow-up. The information about 
medicines entered as ‘discharge letter notes’ was categorised into notes about inpatient 
medication, notes about medication changes, and notes about medication 
recommendations. 
 
In 358 (27%) of the EDS sample no medication notes of any type were entered; this 
included the 82 EDSs that had no ‘discharge letter notes’ entered. The absence of 
medication notes may just reflect that there was no need for a note i.e. there were no 
medication changes or recommendations or inpatient medication treatments of note. 
Alternatively, it may indicate a failure to enter information essential for continuity of 
care. 
 
In 948 (73%) of the EDS sample a ‘discharge letter note’ was entered that contained 
information about medications. The most frequent medication notes written were about 
medication changes (65% of the EDS sample), followed by notes about inpatient 
medication treatments (37%) and medication recommendations (16%). This added up to 
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more than 100% as EDSs could contain more than one category of note and some 
contained all three types. The most frequently occurring combination of medication notes 
was medication changes note only (26% of the EDS sample), followed by medication 
changes note in combination with inpatient medication note (24%), and medication 
changes note in combination with medication recommendations note (9%). The 
frequency of medication changes notes, may reflect that there were more medication 
changes that needed to be communicated to the GP than inpatient medications of note or 
medication recommendations. Alternatively, it may demonstrate that junior doctors are 
more aware of the need to communicate medication changes to the GP. What was not 
known was the frequency of medication changes that occurred and required a medication 
changes note, and whether the medication changes notes were complete and accurate. 
This was considered when evaluating construct validity of medication changes in section 
4.4. 
 
 
4.3.2 Allergies 
 
Allergies data in the EDSs were pre-populated from the patient’s JAC record; therefore 
the information on the EDSs was identical to that presented to the JAC user when they 
were accessing the patient record for the purpose of prescribing, administering 
medication or verification of the prescription (as shown in Appendix 1, Figure 13, and 
Appendix 2). The JAC user would be immediately alerted if allergies data were absent, 
whenever the patient’s JAC record was accessed (as shown in Appendix 1, Figure 6); 
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despite this function, 57 (4%) of the EDSs had no information entered in the allergies 
data field. Allergies data were more frequently absent from S&A EDSs (7%) than M&E 
EDSs (3%).  This may have occurred more frequently in S&A due to the shorter length of 
stay, resulting in less time and opportunity to obtain the information. However, the 
majority of S&A patients would be elective admissions, so one would expect this 
information to have been provided by the GP prior to admission. What was not known 
was how many of the EDSs missing allergies data were emergency rather than elective 
admissions, as this was outside the scope of the study. 
 
The majority of the EDSs (96%) had allergies information entered, and the most frequent 
data were NKDA, followed by drug allergy to a named drug or drugs, and non-drug 
allergy. In three EDSs the data input was ‘allergy status undetermined’, the use of which 
was discouraged as it was potentially more risky than absent data as it fails to alert the 
JAC user when they access the record.  
 
The absence of allergies data and use of ‘allergy status undetermined’ were a patient 
safety risk when communicating medicines-related information via the EDS. More 
importantly it reflected a patient safety risk that had not been addressed during the 
inpatient stay. All EDSs analysed had a ‘drug history note’ and therefore the assumption 
was that medicines reconciliation had been performed on admission, which would 
include determining allergy status and ensuring information was documented. Safer use 
of medicines in people with allergies was highlighted as one of the risks that needed to be 
reduced in ‘Building a Safer NHS for Patients’ (DOH, 2001). Failure to document allergy 
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status posed a risk of errors at the time of prescribing, dispensing and administration. The 
patient’s allergy status was readily accessible with the JAC EPMA and reduced the risk 
of errors related to allergies, unless the data were absent or ‘undetermined’. History of 
allergies was a core part of the patient history and incidents may have occurred where this 
was not accurately or clearly documented in the patients’ notes and JAC record. At the 
RHCH, it was the prime responsibility of the prescriber to ensure that the patient’s allergy 
status was checked before any prescriptions were written. Pharmacy and nursing staff 
dispensing, administering and monitoring medicines could help prevent potential 
incidents by identifying the patient’s allergy status if it had been overlooked. What was 
not known was how often the allergies information was completed by pharmacy staff 
because the doctor had failed to do so, as this was outside the scope of the study; but 
there was less absent allergies data in the M&E division where there were more speciality 
pharmacists.  
 
 
4.3.3 Discharge medication 
 
All TTAs listed on the EDSs were legible and, with a few exceptions, contained complete 
information on the drug, dose, route, frequency, number of days supply and whether the 
GP should continue the medication. The M&E division EDSs had more TTA items than 
the S&A and FS divisions, with a median of seven, five and three TTA items 
respectively. These findings were consistent with the divisional speciality; M&E wards 
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take patients that tend to be on more medications for chronic conditions particularly when 
associated with elderly care. Therefore, these findings add construct validity to the study. 
 
149 (11%) of the EDSs were coded as incomplete, or containing prescribing 
discrepancies or duplicate TTA items. Previous studies showed a similar frequency of 
complete and accurate discharge medications as found in this study, ranging from 87% to 
93%, (Callen et al., 2008; Foster et al., 2002). However, meaningful comparisons are 
problematic as the number and type of errors identified were different to those identified 
in this study.  
 
Duplicate TTAs (66%, n=149) was the most frequent discharge medication anomaly, 
followed by prescribing discrepancies (27%, n=149) and missing data (7%, n=149). The 
JAC system pre-populates the EDS with the discharge medication, and by doing so 
should eliminate the risk of transcribing errors that are frequently shown with written 
discharge summaries or those generated  on an electronic database that is not integrated 
with an electronic prescribing system (Callen et al., 2010). Duplicate prescribing was the 
electronic prescribing equivalent of a transcribing error; not because there had been a 
failure to transcribe the information completely from one source to another, but because 
the prescriber had succeeded in doing so. Duplicate prescribing arose from the 
functionality of the JAC system and how it schedules medication that can be administered 
in a variable dose. A prescriber cannot prescribe one or two tablets as a single order; it 
appears as two linked inpatient orders that are ‘either or’, but cannot appear as a linked 
order on the ‘discharge medication’ list. This was recognised as a risk for TTA 
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prescribing and JAC users were advised not to prescribe as a variable order to mitigate 
this risk when they received their induction JAC training. However, these findings show 
that it still occurs, and it was not always corrected on the TTA when it was clinically 
screened and dispensed in the pharmacy. What was not known was whether the 
incidences identified during this study were at a reduced level because pharmacists had 
intervened, or whether they were never amended because they were either not recognised 
or were considered a minor error. This was outside the scope of the study, but could 
warrant further investigation. Changes could be made to the TTAs by the pharmacist in 
the dispensary, but they would have had to ensure that the ward reprinted the EDSs and 
destroyed old versions, as the majority of EDSs had already been printed off. Of course it 
would all be more straightforward if the TTAs were prescribed correctly in all cases. 
 
Prescribing discrepancies occurred when the prescriber ordered a TTA that could not be 
administered e.g. 5mg capsule to be given as a 2.5mg dose. These occurred when the 
prescriber modified an existing inpatient prescription, and the JAC system did not have 
the functionality to reject the discrepancy. These discrepancies could have been avoided 
by the prescriber writing a new prescription but, as found with duplicate prescribing, this 
did not always occur. 
 
Incomplete TTAs occurred when a drug was not available on the JAC drug database and 
the prescriber had to use the ‘DRUG’ function, which was a free type order only to be 
used temporarily prior to the drug being set up on the JAC system. When the inpatient 
‘DRUG’ order was subsequently selected for TTA, the drug name appeared only as 
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‘DRUG’. This type of error must be corrected, as it poses a medication continuity risk; 
but in ten EDSs in the two month study period this did not happen.  
 
These findings highlight that prescribers require more training and guidance on JAC 
prescribing, and there needs to be an emphasis on the function of the EDS as a clinical 
rather than an administrative document. Likewise, pharmacy staff need more training and 
guidance on intervening when TTA duplicates, discrepancies and omissions occur. 
 
 
4.4 Medication changes 
 
Approximately 10% of the EDS sample was selected to assess the construct validity of 
the medication changes notes documented in the EDSs. The sample comprised 138 EDSs, 
randomly selected and stratified to ensure proportionate sampling by ward. The number 
and type of medication changes were identified by comparing the EDSs with the ‘drug 
history notes’, which showed that medication changes occurred in 96%. Thus the 
majority of patients have changes to their medications during the hospital stay; new 
medications were started more frequently than admission medications were stopped or 
changed, and 51% had medication changes of both types. 
 
The 132 EDSs that were associated with medication changes of any type were reviewed 
for the presence of information about medication changes in the form of a list of 
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medication and stating reasons. One would expect that the same number of EDSs should 
contain information about medication changes.  
 
Where new medications were started, 49 (41%, n=120) of the EDSs contained no 
information about the new medications, in 27 (22%, n=120) there was complete 
information about the new medications, and in the remaining 44 (37%, n=120) EDSs the 
information was incomplete. In 38% of the EDSs these were short term courses of 
medications only e.g. analgesia prescribed as required and GP not to continue. However, 
the individual will make decisions about what is important to record or not e.g. is it 
important to list as a change a medication that is a short term course of treatment? 
 
Where admission medications were stopped or changed, 49 (60%, n=82) of the EDSs 
contained no information about changes to the admission medications, in 13 (16%, n=82) 
there was complete information about changes to the admission medications, and in the 
remaining 20 (24%, n=82) EDSs the information was incomplete. No admission 
medications were prescribed on any of ward F1 EDSs. This suggested that doctors on F1 
utilised the EDSs, within the context of medication documentation, as a prescription for 
new medications only, which is contrary to the discharge policy, which states that the 
TTA must include all medication the patient is currently taking, including patient’s own 
drugs and TTA pre-packs (WEHCT, 2009). This ward was short stay surgery and there 
would not normally be a need to stop admission medications, therefore, it was judged 
more likely that the TTAs were not written than stopped. If this was the case then it may 
be a source of bias; as four F1 EDSs were categorised as having admission medications 
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stopped or changed with no information entered in the EDS. In itself, the practice of not 
writing admission medication on the EDSs, may not pose a risk for patients discharged 
from F1 if the GP assumes that the admission medications were unchanged and makes no 
changes to the repeat medications list. The problem lies in how information or lack of it 
in the EDSs was interpreted in different GP surgeries and by different grades of staff. If 
one wishes staff to assume that admission medications omitted from the TTA with no 
explanation were unchanged, then when medications were omitted intentionally with no 
explanation, one must expect those medications to be restarted by the GP. Doctors should 
document in the EDS when medication has been intentionally stopped, but the results 
demonstrate that it is less likely that the doctor writes a note about changes to admission 
medication than new medications started. One simple solution would be for the doctors 
on F1 to explicitly document that there are no changes to the patient’s pre-admission 
medications as a result of hospital admission, and this may be usefully included as a 
function to pre-populate the EDSs. 
 
Information about changes to admission medications, whether incomplete or complete, 
occurred less frequently than information about new medications started. 
 
Overall, 44 (32%, n=138) of the EDSs contained no information about changes to 
medications; six of the EDSs had previously been coded as having a medication changes 
note, but the note was a ‘drugs modified note’ that was misleading. In 18 (13%, n=138) 
there was complete information about changes to medications, and in 70 (51%, n=138) 
the information was incomplete. The remaining six EDSs had no medication changes that 
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required a medication changes note; two of these had previously been coded as having a 
medication changes note, but the note was a ‘drugs modified note’ that was misleading. 
Thus, the ‘drugs modified note’ was associated with miscoding of medication changes 
notes. 
 
There was potential for the majority of EDSs (96%) to have medication changes 
documented. There was the functionality to add notes, which was utilised primarily by 
doctors to communicate information to the GP in 92% of EDSs. The practice was for the 
junior doctor to prepare or change the EDS on the day of discharge, so there should be no 
reason why the information on medicines relating to the changes could not reflect all 
changes including last minute changes. However, only 69% contained a medication 
changes note. The reliability of the medication changes note was assessed by calculating 
the kappa statistic, which showed a good strength of agreement between two independent 
coders. Fewer EDSs (13%) contained complete and accurate information about the 
medication changes. Clearly there was a gap between the need for medicines-related 
information and provision of complete and accurate information. This was either not 
being recognised by the doctors preparing the EDSs, or was not being given priority. The 
gap in the need for and provision of medicine-related information, was also not being 
recognised by pharmacists; although pharmacist letter notes always contained 
information about medication changes, they were only found in 6% of the EDSs. 
 
The rates of medication changes is subject to bias depending on the standard set; if the 
mere presence of information in the EDS about medication changes indicates quality then 
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a high rate (69%) will be achieved; if completeness and accuracy indicates quality then a 
low rate (13%) will be achieved. In assessing completeness and accuracy, the different 
types of medication changes need to be considered. This study included all types of 
medication changes, however, in Australian hospitals, quality indicators for medication 
changes to the patient’s pre-admission medication regimen only includes those which are 
intended to continue after discharge (NSW Therapeutic Advisory Group, 2007). 
Following this definition would not necessarily increase the rate of medication changes 
measured, as in general doctors were more likely to document short term courses of 
medication at discharge.  
 
 
4.5 JAC upgrade 
 
During the study, on 24
th
 July 2010, the JAC system was upgraded to version 4.47. The 
upgrade had several additional features, which included two new note types: ‘note to 
appear in EDS’; and ‘drugs modified note’. The ‘note to appear in EDS’ allowed the JAC 
user to add notes throughout the patient stay that were pre-populated into the EDS when 
it was prepared. The ‘drugs modified note’ generated a summary of all changes to 
medicines marked ‘admitted on drug’, which was pre-populated into the EDS when it 
was prepared.  Ideally medication changes should be logged during the hospital stay, and 
these two new note types appeared to offer a solution. However, the data shows that the 
‘note to appear in EDS’ was used infrequently and only by pharmacists, and the ‘drugs 
modified note’ was mostly misleading. There were nine ‘notes to appear in the EDS’, and 
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61 ‘drugs modified notes’ in the EDS sample. The 138 EDSs, which were analysed for 
medication changes, were checked for the presence of these two new notes. There were 
nine ‘drugs modified notes’, of these three were correct and six were misleading. The 
reason for the notes being misleading was that the note appeared for an unchanged 
admission drug. To understand why these notes are misleading one needs to know how 
the notes are generated. They only occurred if the prescriber marked the medicine as 
‘admitted on drug’ when it was initially prescribed. If it was a prescribing error, which 
was then identified when medicines reconciliation was completed, the pharmacist made 
an intervention and corrected the prescribing error. This was then logged by the system as 
a change to admission medication, when the reality was a correction to admission 
medication. The ‘drugs modified note’ in the EDSs was then misleading. The inherent 
problem was that the JAC system’s core assumption is that the doctor does not make any 
prescribing errors on the admission drugs, which is not borne out by the prevalence of 
errors shown in the EQUIP study (Dornan et al., 2009). An improvement would be to 
activate the ‘admitted on drug’ function at the medicines reconciliation stage, and make it 
available only to pharmacy staff. 
 
 
4.6 The interdependence of technology and human factors 
 
Although EDSs were legible and were found to have the potential for more timely 
communication with the GP, safe continuity of care depends on the provision of accurate 
and complete information (NHS Alliance, 2009b). Introducing new technology, in the 
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form of an EDS, may improve patient safety by avoiding some types of error, but can 
introduce new types of error if systems and processes fail to take account of the interface 
between people and technology. The functionality of the JAC EPMA ensured that some 
sections on the EDS were automatically pre-populated with data that had already been 
entered. However, this did not ensure that it was always complete and accurate.  
 
The frequency with which EDS content occurred was in part dependent on the degree of 
automation. The greater the input required by the JAC user the less frequently the 
information was complete and accurate. The prescribing of a TTA automatically 
generated an EDS, therefore, in 100% of cases a legible EDS was prepared that contained 
patient details, admission details and discharge medications pre-populated from the JAC 
EPMA. In terms of the EDS being prepared and printed ready for issue at the point of 
discharge, this required the doctor to select to ‘complete’ the EDS and print it (default 
option). Thus, 97% of the EDS sample were ‘complete’ and printed at discharge, because 
some EDSs had not been printed by the doctor or were provisional. Allergies data, 
although pre-populated, was dependent on data having been entered onto the patient’s 
JAC record. Thus, 96% of the EDS sample had allergies information entered. The 
‘discharge medication’ list, although pre-populated, was dependent on the correct and 
accurate selection of TTAs by the doctor. Thus, 89% of EDSs contained complete and 
accurate ‘discharge medication’ lists, with duplicate prescribing, discrepancies and 
missing data occurring because of how the prescriber was using the system. 
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‘Discharge letter notes’ were manually entered and were written for 94% of the EDSs, 
mostly by doctors. These notes could contain information about any aspect of the episode 
of care. In 73% of EDSs the ‘discharge letter note’ contained medicine-related 
information, most frequently about medication changes, even though 96% were judged to 
have medication changes. Evaluation of the medication changes notes showed that 
complete and accurate information about medication changes occurred less frequently. 
Improvements that could increase the quality of information about medication changes 
include the systematic recording of changes to medication, and the reasons for these, in 
the form of the ‘note to appear in EDS’ and ‘drugs modified note’. However, it was found 
that these functions were used infrequently and could result in misleading information 
when used inappropriately. 
 
The use of non-standard processes by various healthcare professionals can compromise 
the quality of medicines-related information in the EDS, as well as other essential 
information. Poor continuity of information within the hospital, where information has 
not been reconciled or corrected, can have implications for the continuity of care when 
the patient is discharged from hospital to the care of their GP.  The study raised questions 
about the accuracy of the consultant team coding, caused by doctors being able to 
‘manually admit’ patients; which could affect the GP’s ability to contact the correct team 
post-discharge should they need to. The WEHCT (2009) discharge policy required 
doctors to prescribe all medications the patient was currently taking, despite this there 
were some cases where none of the patient’s admission medications were on the TTA. 
This was particularly evident on ward F1, and raised questions about the completeness 
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and accuracy of ‘discharge medication’ lists on the EDSs that were being communicated 
to the GP. The only TTAs written were for short term courses of medications that needed 
dispensing. Therefore, it appeared that EDSs may be used by some doctors for the 
purpose of prescribing TTAs that require dispensing, and not for communicating clinical 
information to the GP; ward F1 also had the highest proportion of EDSs with no 
‘discharge letter notes’ written. 
 
The use of non-standard processes in the dispensary to generate a TTA dispensing list, 
when the EDS was provisional, raised questions about the reliability of pharmacist 
checking processes in the dispensary. The cases where none of the patient’s admission 
medications were on the TTA also raised questions about the reconciliation of the TTA in 
the dispensary. This may show that checking processes in the dispensary were sometimes 
omitted, or they occurred but the error was not identified, or the error was identified but 
not fully resolved. So pharmacy staff may be complicit by not intervening on TTA 
discrepancies, anomalies and incomplete data, and dispensing from provisional EDSs 
when TTA dispensing lists are not generated on the  JAC. 
 
The discharge summary may be viewed by hospital doctors as a record of events but may 
be better viewed as a referral back to primary care, requiring sufficient information for 
immediate continuity of care. There is a need for education of junior doctors, pharmacists 
and nurses about what is necessary for high quality medicines-related information in the 
EDS; with an emphasis on the function of the EDS as a clinical and not just an 
administrative document. 
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4.7 What the study adds 
 
The findings support the benefits of EDSs in generating legible and timely EDSs that 
contain medicines-related information that is mostly complete and accurate. 
 
Previous studies of the quality of medicines-related information in the EDS have been 
limited by a lack of clear definitions of what the content of medicine-related information 
should be. This study has defined the key medicines-related information that should be 
included in the EDS, and measured the content of the medicines-related information 
using a large sample size to reduce error in generalising findings from the sample. 
 
 Previous studies have utilised manual entry of medication details onto the EDS, with the 
associated risk of transcribing errors. This study evaluated a system where much of the 
medicines-related information on the EDS was pre-populated from the JAC EPMA, and 
has shown that automation can influence completeness and accuracy of medicines-related 
information. 
 
Medication changes often occur during the hospital stay and there have been no studies 
published specifically evaluating information about medication changes. This study has 
measured the frequency and type of medication changes that occur and whether 
information about medication changes was complete and accurate.  
 
 127 
This study has implications for NHS hospitals considering implementation of electronic 
prescribing and medicines administration systems, such as the JAC EPMA. There are 
clear benefits of legibility and timeliness of the EDSs, and completeness and accuracy of 
medicines-related information where it is pre-populated. Implementation has to be 
supported with comprehensive training of staff to ensure the quality of medicines-related 
information in the EDS. 
 
 
4.8 Limitations of the study design 
 
There were some sources of potential bias identified, including reliability of the 
consultant name on the EDS, introduction of two new note types during the study, 
provisional EDSs, and coding of medication changes where admission medications were 
not selected for TTA. Identification of the scale of these problems was outside of the 
scope of the study. However, potential bias due to the high latent content of the 
medication changes note was addressed by measuring inter-coder reliability and 
calculating the kappa statistic. 
 
The JAC upgrade was a limitation of the study as the use of the two new types of notes 
was a new practice. Thus, the ‘note to appear in EDS’ was not used extensively, and the 
‘drugs modified note’ was being inappropriately used. 
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The methodology introduced potential bias towards EDSs from the M&E division, by 
excluding all EDSs with no associated drug history. Thus the EDSs of patients that were 
day cases or overnight stays were disproportionately excluded, and the S&A and FS 
divisions under-represented in the EDS sample. This problem was partly mitigated by the 
large sample size. Alternatively, this exclusion criterion could have been applied prior to 
assessing construct validity, but this would have made randomly selecting and stratifying 
10% of the EDS sample problematic, due to the differences in recording of ‘drug history 
note’ between wards within divisions. 
 
The assumptions made in designing the study were that the ‘drug history note’ indicated 
medicines reconciliation at admission, and that selecting the EDSs from TTA dispensing 
lists processed by the dispensary indicated that the TTA had been clinically checked by a 
pharmacist and that medicines reconciliation at discharge had occurred. This may not 
always be the case, and may have introduced bias if these processes have not occurred. 
After the pilot some TTA dispensing lists that did not result in dispensing were included 
in the study, and these may not have been fully clinically checked by a pharmacist. 
Therefore, completeness and accuracy (as measured) was restricted to completeness and 
accuracy of medicines-related information on the EDS. It was assumed (by study design) 
that there were no omissions of medications from the ‘discharge medication’ lists or 
incorrect dosage instructions or allergies data. In terms of timeliness it was only assessed 
by measuring if the EDS was ready to be sent to the GP when the patient was discharged, 
not that it was subsequently sent, received by the GP surgery and the information 
processed and entered onto the patient record.  
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4.9 Recommendations for future studies 
 
There are no easy solutions to the problem of improving the quality of the medicines-
related information in the discharge summary. Often EDSs are seen as a means of solving 
the problem, but the issue of quality is more complicated than simply measuring if there 
is a list of discharge medications or that medication changes have been documented, as 
this is a complex system. The concept of quality in health care is multidimensional and 
complex, and some of the questions asked about the quality of medicines-related 
information may not be amenable to quantitative measurement.  
 
Qualitative research would complement this quantitative study, as it emphasises the 
importance of understanding, from the viewpoint of the people involved, how individuals 
and groups interpret, experience and make sense of social phenomena (Robson, 2002). 
The emphasis in qualitative research on understanding meanings and experiences makes 
it particularly useful for quality assessment and understanding the complex issues 
inherent to quality improvement. Views of quality depend on the individual perspective; 
the patient, pharmacist, hospital doctor, or GP may all have contested views of what 
constitutes high or poor quality EDSs. Much depends on the perspectives of the users and 
the attitudes and behaviours of professionals in the context of their organisations and 
healthcare teams.  
 
Future studies could evaluate the experiences, attitudes and behaviours of prescribers in 
preparing EDSs, and how this could influence the quality of EDSs. In addition the 
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experiences, attitudes, and behaviours of pharmacists screening TTAs in the dispensary 
could be evaluated, as well as how this could influence the quality of the EDSs. 
 
The sources of potential bias identified during the study, including reliability of the 
consultant name on the EDS, introduction of two new note types during the study, 
provisional EDSs, and coding of medication changes where admission medications were 
not selected for TTA, may warrant further study to identify the scale of these problems. 
 
Timeliness of the EDS preparation just identified if the EDS was ready at the point of 
discharge. Further study to evaluate when the EDS was received at the GP surgery and 
how it was processed and incorporated into the patient record would be valuable in 
identifying potential delays in communication of medicines-related information between 
secondary and primary care. 
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Section 5 Conclusion 
 
EDSs make an important contribution to patient safety in generating legible and timely 
medicines-related information; but do not completely eliminate the risk of inaccurate or 
incomplete information. Opportunities still exist for human factors to have an impact. 
The JAC system was effective in generating EDSs in a timely manner in 97% of the EDS 
sample. The EDSs contained the following types of medicines-related information: 
allergies data; discharge medication list; and medication notes. 
 
Where medicines-related information was pre-populated from the JAC system, as was the 
case with allergies data, the ‘discharge medication’ list and ‘drugs modified note’, it was 
always legible but not always complete and accurate. 
 
The EDSs contained complete and accurate allergies data in 96% of the EDS sample. The 
JAC system was effective in pre-populating the allergies data field; but if allergies data 
were not entered during the inpatient stay, they were not available for the EDSs. 
 
The EDSs contained complete and accurate ‘discharge medication’ lists in 89% of the 
EDS sample. The JAC system was effective in pre-populating the ‘discharge medication’ 
list, which eliminates transcribing errors, but did not completely eliminate incomplete, 
duplicate or inaccurate information.  
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The ‘drugs modified note’ was not effective in documenting complete and accurate 
information about medication changes in the EDS; in two thirds of notes, the information 
was misleading. 
 
Where medicines-related information was manually entered, as was the case for 
medication notes entered as ‘discharge letter notes’, it was always legible but not always 
complete and accurate. The EDSs included a medication note in 73% of the EDS sample. 
The most frequent type of medication note was a medication changes note (65%). 
 
Medication changes occurred, between admission and discharge, in 96% of cases; new 
medications were started more frequently than admission medications were stopped or 
changed. Where new medications were started, there was complete and accurate 
information in 22% of the EDSs. Where admission medications were changed, there was 
complete and accurate information in 16% of the EDSs. Documentation of information 
about medication changes was frequently incomplete or inaccurate; overall only 13% of 
the EDSs contained complete and accurate information about all types of medication 
changes. Therefore, there was a gap between the need for information about medication 
changes and provision of complete and accurate information. 
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5.1 Recommendations 
 
There is a need for improved education of junior doctors, pharmacists and nurses in the 
more effective use of the EDS in communicating medicines-related information to the 
GP; with emphasis on the function of the EDS as a clinical rather than an administrative 
document. 
 
There is a need to address the incorrect consultant’ name being recorded on the EDSs, by 
minimising, or identifying more effectively, manual admissions onto the JAC system. 
 
There is a need to minimise the number of patient JAC records with absent allergies data, 
through feedback to Medicines Management technicians and pharmacists involved in the 
medicines reconciliation process. 
 
There is a need to address the inappropriate practice of some doctors prescribing only 
TTAs that required dispensing, and not the patient’s admission medications, as well as 
how it is identified as a prescribing error and resolved in the dispensary. 
 
There is a need to change how the ‘drugs modified note’ is activated within the process of 
prescribing, reconciliation and verification. Activating this note should be part of the 
reconciliation and verification process performed by Medicine Management technicians 
and pharmacists, and not by the doctor within the prescribing process. 
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Section 6 Reflection on study undertaken 
 
When I entered the Professional Doctorate course I did so with the express desire of 
conducting research into communication of medicine-related information between the 
hospital and GP. The research topic emerged from working as a clinical pharmacist in the 
division of medicine and care of the elderly. I had been aware for some time that when a 
patient was discharged from hospital, the communication of medicine-related information 
between the hospital and the GP was often of poor quality, and did not always meet the 
needs of the recipient. This knowledge came from reading the published literature 
combined with my experience as a clinical pharmacist. My interest in electronic 
discharge summaries in particular emerged from working at the Royal Hampshire County 
Hospital. When I started working at the Royal Hampshire County Hospital, which had 
electronic prescribing, I also became aware that the use of electronic discharge 
summaries was not the panacea that some authors regarded it as. Working within an 
electronic prescribing environment I knew that problems with communication at 
discharge still occurred; maybe different problems, or on a different scale, but it by no 
means resolved the problem. However, I could still see the potential for electronic 
discharge summaries to improve communication between the hospital and GP; and the 
potential for pharmacists to improve the communication of medicines-related information 
at the interface 
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While working on the medical admissions unit, I remember being struck by the scale of 
the problem of the ‘revolving door’ of admission, discharge and readmission of patients. 
In particular, the image of the same patient on the same ward, in the same bay, in almost 
the same bed as they were two weeks previously; having been discharged and readmitted 
in that space of time. Unsurprisingly, given all the other similarities, the drug history 
from the GP was the same as the previous admission, despite substantial changes having 
been implemented during the previous admission. The lack of continuity of care was 
striking. The changes made in the hospital didn’t appear to have been actioned by the GP. 
Then it became clear that in the same way I felt frustrated by poor communication from 
the GP, the GP must feel frustrated by poor communication from the hospital. It was as 
easy to blame the GP for not acting on the new treatment plan, as it was for the GP to 
blame the hospital for not communicating in a timely and effectively way about the 
patient’s hospital admission and treatment. A lot of time and resources were being wasted 
because of poor communication between the hospital and GP, and the individual who had 
a right to feel frustrated was the patient. 
 
I was clear about my research topic; the quality of medicines-related information in 
electronic discharge summaries. What was less clear was the methodology I should use, 
and the Professional Doctorate enabled me to appraise different designs. My desire to 
implement a pharmacist based intervention within a randomised controlled trial was 
tempered by the reality of resource limitations. Therefore, a pragmatic approach was used 
in undertaking a content analysis of the medicine-related information in the electronic 
discharge summary. Since this journey began I have seen lots of changes: Agenda for 
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Change; PCTs merging; a new electronic prescribing system implemented; new 
managers; speciality pharmacists come and go; more research publications; and new 
policies and guidelines published. One thing remained constant during a period where 
much has changed; GPs still complained that they didn’t get enough information from the 
hospital. What had not changed was that we still did not have a cure for the problem of 
poor communication between the hospital and the GP.  
 
Through undertaking the study, I have answered my research question; I know how much 
medicine-related information is in the electronic discharge summary. I also know that this 
information is not always complete and accurate, particularly when communicating 
changes to the medication regimen, which happen frequently. The research study has 
identified the scale of the problem at the Royal Hampshire County Hospital, there is 
further to go to achieve the improvements that are required. It also highlighted how 
human error still remains a powerful factor, even within an electronic prescribing 
environment. Thus, new questions emerge about why the information is not complete and 
accurate, and how to improve the quality of medicine-related information. 
 
I believe that pharmacists are an untapped resource, which can help ensure that when 
patients’ are discharged their electronic discharge summaries contain accurate and 
complete information about medicines. The role of the pharmacist in medicines 
reconciliation at admission has become embedded within practice. What I would like to 
see is the role of the pharmacist in medicines reconciliation at discharge become 
embedded in the same way as a core function. Medicines reconciliation at discharge 
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requires more than the reconciliation of the discharge medicines against the inpatient 
prescriptions; it also requires reconciliation of the discharge medicines against the 
admission drug history.  
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 II 
1. The JAC system 
 
JAC provides pharmacy stock control, e-prescribing and medicines administration as a 
single integrated solution supported using the Multilex Drug Data File (UK) provided by 
FirstDataBank Europe. 
 
The JAC Electronic Prescribing and Medicines Administration system combined with the 
Pharmacy Management system provides clinical and administrative support to 
prescribers, pharmacists and nurses throughout the medicines process. Functionality 
includes drug ordering, stock control, ward stock top-up, dispensing, labelling, 
prescribing with clinical decision support and administering to patients. 
 
1.1. JAC’s Pharmacy Management system 
 
The Pharmacy Management system’s basic functionality includes: stock control; order 
and delivery processing; invoice and credit handling; dispensing; ward stock; reporting; 
accounting; and manufacture and trading.  
 
The Pharmacy Management system is fully integrated with the Electronic Prescribing and 
Medicines Administration system. Any prescribed items that are non-stock, or required 
on discharge, short-term leave or outpatient prescriptions will be immediately available 
for dispensing within the pharmacy system. This integration with the pharmacy module 
also eliminates prescription transcription, reducing the potential for errors in the 
dispensing process, as well as simplifying the process through the automated pass 
through of information that would otherwise have to be manually entered. 
 
 
 
 
 
 
 III 
1.2. JAC’s Electronic Prescribing and Medicines Administration (EPMA) system 
 
Full EPMA includes integrated in-patient and out-patient prescribing, discharge 
prescribing, decision support for providing warnings on allergies, drug-drug interactions 
and therapeutic duplicates, as well as bed-side medicines administration support and 
recording. A variety of functions are provided to support the entry and maintenance of the 
inpatient prescription. This also incorporates functionality to support discharge 
prescribing and short-term leave. 
 
The EPMA system functionality includes: capture of patient demographics; inpatient 
prescribing; decision support; formulary management; clinical pharmacist verification; 
clinical notes; nurse administration; discharge prescribing with discharge letter; short-
term leave prescribing; and outpatient prescribing. 
 
1.2.1. Patient demographics 
 
Patient demographics are stored and updated automatically to support the retrieval of 
current and historic medication information as well as to aid clinical decision support. 
The JAC system also gathers detailed allergy, height and weight information which can 
be entered during the inpatient admission.  
 
The demographic information is typically received from the Trust PAS or third party 
system as a specified sub-set via an inbound HL7 interface feed. The information is 
immediately available (as illustrated in Figure 1) when the prescriber accesses the patient 
record, and provides further prescriber support through functionality such as dosage 
calculators and clinical checking of medicines selected. 
 
 IV 
              
Figure 1: Prescriber Order Entry screen displaying demographic information  
 
Elective patients with a future admission date can also be received into the system in a 
pre-admission environment. This environment supports the entry of patient prescriptions 
in advance. The system will then automatically schedule the prescription (subject to 
review based on local policies) when the patient is admitted on the appropriate date. 
 
 
 
 
 
 
 
 
 
 V 
1.2.2. Prescribing of individual medicines 
 
The prescriber chooses the medicine that they wish to prescribe from a locally defined 
catalogue that will reflect the hospital formulary, as illustrated in Figure 2.  
 
 
Figure 2: Drug Selection screen for beclometasone 
 
Once a medicine is selected, the prescriber will be presented with a variety of default 
information for the drug, i.e. route, dose, and frequency of administration as illustrated in 
Figure 3. Any of the defaults can be changed, as well as further information added where 
required. The default information presented for any drug is locally defined. In many cases 
the default options allow the drug to be prescribed without any changes, requiring a 
single key press to confirm the request.  
 VI 
 
Figure 3: Medication Order Entry screen for beclometasone (Qvar) 100mcg inhaler 
 
Prescribing of ‘as required’ or PRN drugs such as pain relief are supported, with text 
boxes to indicate reasons for administration which will support nursing staff. The 
prescribing of once-only orders or STAT medications are also supported, with the ability 
to record administration immediately, or in the future. It is possible to link a once-only 
order with a regular ongoing prescription such as that a dose is given now, and the order 
is scheduled to continue in the future. Treatment courses are fully supported in terms of 
the number of days or doses that the prescription will be active. Default information can 
be presented for products such as antibiotics, and the system further supports this through 
the optional definition of linking stop dates to indications. Other notes can be added at the 
point of prescribing relating to a product prescribed for a patient which can be set to 
display in various points of the prescribing and administration processes, as described and 
illustrated in section 1.2.8. 
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1.2.3. Clinical decision support 
 
Drug interaction checking, therapeutic duplicate checking, allergy checking and drug 
monographs functionality (as illustrated in Figure 4) is available and supported using the 
Multilex Drug Data File (UK) provided by FirstDataBank Europe. This decision support 
is provided at the point of prescribing.  
 
 
Figure 4: Clinical Drug Database Information screen for beclometasone 
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For example, where a drug is prescribed to which the patient has been marked as 
potentially allergic, the system will provide an alert to the prescriber as illustrated in 
Figure 5. The prescriber will be given the option to continue providing they enter an 
override reason defined by the Trust, or they may discontinue the order and choose an 
alternative product.  
 
 
Figure 5: Drug Conflict screen when selecting flucloxacillin in penicillin allergy 
 
Drugs prescribed which may interact with or duplicate drugs previously prescribed that 
are still active on the prescription will also display an alert. For these types of alert the 
prescriber may choose to discontinue a drug which conflicts in addition to the options of 
giving a reason for continuing to prescribe and/or cancelling the prescription. All actions 
taken by prescribers relating to decision support are logged for clinical review. 
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If no allergy information has been entered previously, the prescriber is prompted to enter 
this data when they access the patient record, as illustrated in Figure 6. 
 
 
Figure 6: Patient Allergy Maintenance screen which prompts prescriber to enter 
allergy information 
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1.2.4. Changing the prescription 
 
A variety of functions are provided to support the ongoing changes required to the patient 
prescription. The system supports modification, discontinuation, suspension and 
resumption of any and all items prescribed for the patient. The reason for modifying, 
discontinuing or suspending the prescription can be added before accepting the change, as 
illustrated in figure 7. 
 
 
Figure 7: Suspend Medication Order screen including default reason codes 
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1.2.5. Clinical pharmacist verification 
Clinical pharmacist verification is a function for pharmacists to clinically check a 
prescription. The verification process changes the status of the prescription and this 
information is clearly displayed to all users of the system, regardless of the function in 
which they deal with the patient. Verification provides clarity for nursing staff that the 
prescription has been clinically reviewed. Any prescription generated by a doctor is 
treated as unverified (blue) and when verified by the pharmacist it is easily identifiable as 
the order is white as illustrated in Figure 8. Standard reports are provided for pharmacists 
to identify changes to patient prescriptions on the wards without having to be physically 
present on the ward. The verification process includes functionality to support medicines 
management. This allows information such as whether the patient was admitted on the 
medicine, have their own supply, and whether they are self administering to be recorded. 
 
              
Figure 8: Prescriber Order Entry screen illustrating verified (white) ‘regular’ and 
‘as required’ medications and unverified (blue) ‘TTA’ medications 
 XII 
1.2.6. Nurse administration 
 
Whenever the administration functionality is accessed, the system will display the 
medicines due for the patient based on the current date and time. Medicines are recorded 
as given by entering the date and time; this can be achieved by a simple double click on 
the relevant field. Where administrations are not given, a drop down list is available to 
elect from a choice of Trust defined reasons for non-administration. Reasons for non-
administration can be linked to routes of administration to simplify the process of 
recording information for a number of medicines e.g. if the patient is nil by mouth, all 
ORAL medicines can be flagged in a single action. Access to clinical monographs and 
the ability to add notes to the patient record are both features of the administration 
process. Where the administration requires witnessing by another nurse, an authorised 
user will be required to enter acknowledgement that the administration was observed 
through entry of their username details into the system. Support for patients who are self 
administering is also provided. Those medicines which the patient is self administering 
are highlighted for nursing staff. Information available from within the main 
administration window identifies when doses of medications were last administered, the 
date and time of the last dose, and who recorded the administration, as illustrated in 
Figure 9. This information is provided for the entire admission, in addition to a report 
which is available to review the last 24hours administrations. All information relating to 
administration is accessible from a single window. 
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Figure 9: Patient Administration Chart screen illustrating administration status of 
prescribed drugs 
 
 
1.2.7. Medicines management module 
 
The Medicines Management module is designed to support pharmacy staff on the wards, 
and will allow the patient prescription profile to be entered and maintained throughout the 
inpatient admission.  
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1.2.8. Clinical notes 
 
Within both prescribing and administration functions, clinical notes may be added, 
modified, discontinued or viewed. Clinical notes may be added to the patient record or to 
the drugs that have been prescribed. Notes that are associated with drugs on the patient 
prescription can automatically be set to be suppressed when the prescription stops. 
Notes are grouped into categories by the trust, for example notes can be added to 
document the drug history. Whenever clinical notes have been associated with a patient, 
they are displayed upon patient selection, as illustrated in Figure 10.  
 
 
Figure 10: Select Note screen when accessing patient 
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Clinical notes are highlighted in different colours to represent whether a user has 
previously seen the information being displayed; yellow indicates an unread note, green 
indicates a read note. All notes are date and time stamped with the user who added the 
information, as illustrated in Figure 11.  
 
 
Figure 11:  Content of Drug History Note 
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1.2.9. Discharge prescribing 
 
The system supports discharge prescribing and the generation of an electronic discharge 
summary (EDS); incorporating the active medicines profile for the patient, and drugs 
required for dispensing at discharge. The discharge function facilitates the selection of 
medicines for the patient to take home in addition to the quantity to supply, and whether 
the GP should continue treatment. The ‘discharge medications’ function is accessed via 
the Prescriber Order Entry screen, as illustrated in Figure 12. The prescriber can add a 
new order or select inpatient medications for TTA, as illustrated in Figure 13. 
 
 
Figure 12: TTA Discharge Medications screen showing current TTA medications 
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Figure 13: Select Orders for TTA screen showing selection of salmeterol, 
beclometasone and salbutamol inhalers for TTA 
 
The EDS, accessed via the ‘discharge medication’ screen, also provides a mechanism to 
enter further information about the patient. Doctors, nurses, and pharmacists all have 
relevant sections which can be populated with information, as illustrated in Figure 14. 
The EDS is pre-populated with discharge medications as well as patient demographic 
information. Any medicines upon admission that have changed or been stopped within 
the admission will be automatically added to the EDS with reasons for change.  
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Figure 14: Discharge Letter Entry screen showing doctor, nurse and pharmacist 
notes  
 
When the discharge prescription and summary are complete the prescriber has to confirm 
by selecting ‘Yes’, as illustrated in Figure 15. The prescriber is then offered the option to 
print the EDS, as illustrated in Figure 16, which when selected prints three copies for the 
GP, notes and patient. 
 
 
Figure 15: TTA and Discharge Letter Complete screen 
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Figure 16: Discharge Letter Print screen 
 
As the EDS is completed on the ward, any medicines that require dispensing are 
automatically made available within the dispensing module and may be scheduled based 
on an indicated urgency. The prescription is dispensed following clinical verification by a 
Pharmacist.  
 
1.2.10. Short-term leave 
 
In addition to the discharge prescribing functionality, a prescription may be created for a 
patient who is leaving the hospital for a short period of time. This functionality is known 
as short-term leave. When a short-term leave prescription is generated, the prescriber will 
enter the anticipated date and time that the patient will both leave and return to the 
hospital. When the medicines are selected for the prescription, the system will calculate 
the supplies required for the time period that the patient will be on leave. As the short-
term leave prescription is completed on the ward, any medicines that require dispensing 
are automatically made available within the dispensing module and scheduled based on 
an indicated urgency. When the patient leaves the ward, nursing staff mark the patient on 
leave, and this suspends all inpatient prescriptions and marks all doses due for 
administration with information that the patient is on leave. When the patient returns to 
the hospital all inpatient prescriptions are re-activated. 
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 XXVIII 
Standardised document abstraction form for EDS – version 1 
 
 
Category 
 
Data Source of data Coding instructions 
General 
information 
   
Date dispensing list 
retrieved 
DD/MM/YY Dispensing list 
print-out 
Enter date from dispensing list print-out 
Date of admission DD/MM/YY Date of admission 
on JAC EPMA 
Enter date of admission as it appears on JAC EPMA 
Date of discharge DD/MM/YY Date of discharge on 
JAC EPMA 
Enter date of discharge as it appears on JAC EPMA after the 
episode of care is closed when patient discharged 
Day of discharge Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
Date of discharge Code day of week from date of discharge entered 
Month of discharge July 
August 
Date of discharge Code month of discharge from date of discharge entered 
Length of stay Whole number 
(commencing at 1) 
Date of admission 
Date of discharge 
Calculate length of stay by counting the number of days 
between date of admission and date of discharge, each day or 
part day is counted as one day 
Ward F1 
M1 
M2 
M3 
M4 
Ward name on JAC 
EPMA 
After the episode of care has been closed when patient 
discharged, identify ward that issued EDS as it appears on JAC 
EPMA. Code as listed in Table 2.1. 
 XXIX 
M5 
M6 
M7 
S1 
S2 
S3 
S4 
Division M&E 
S&A 
FS 
Ward code Code division from ward code entered, as categorised in Table 
2.1. 
Drug history note 
recorded 
Yes 
No 
‘Drug history note’ 
recorded on JAC 
EPMA 
Has a ‘drug history note’ been recorded on JAC? After the 
episode of care has been closed when patient discharged, check 
if a ‘drug history note’ was recorded on JAC EPMA 
Unique 
identification 
number 
e.g. S1/001 Ward code and 
‘Yes’ in drug 
history note 
recorded 
When EDS meets all inclusion criteria allocate a unique 
identification number comprising ward code/three digit number 
commencing at 001 and allocated sequentially by date of 
discharge 
Preparation of the 
EDS 
   
Consultant by 
division 
M&E 
S&A 
FS 
Consultant name on 
EDS 
Code consultant name by division working in, as categorised in 
the published bleep list 
Grade of doctor 
preparing the EDS 
F1 
F2 
Registrar 
Consultant 
Doctor name on 
EDS 
Code name of doctor preparing EDS by grade, using the 
published bleep list for the period during which the EDS was 
prepared 
Letter status ‘Complete’ 
Provisional 
Letter status on EDS Code from print record on footer/header of EDS as follows: 
‘Complete’ = date printed on footer of EDS 
Provisional = ‘PROVISIONAL’ on header of EDS 
 
 XXX 
Date EDS 
printed/revised 
DD/MM/YY Date originally 
printed/revised on 
EDS 
Enter date ‘originally printed’ or ‘revised’ from print record on 
footer of EDS. If ‘originally printed’ date and ‘revised’ date 
occur together enter ‘revised’ date 
Preparation of EDS 
prior to discharge 
Day of discharge 
Day before 
discharge 
Two days before 
discharge 
Three or more days 
before discharge 
Date EDS originally 
printed/revised 
Date of discharge 
Code by comparing the date originally printed/revised with the 
date of discharge 
Doctor letter notes Yes 
No 
Doctor letter note on 
EDS 
Has a ‘discharge letter note’ been entered on EDS by doctor? 
Pharmacist letter 
notes 
Yes 
No 
Pharmacist letter 
note on EDS 
Has a ‘discharge letter note’ been entered on EDS by 
pharmacist? 
Nurse letter notes Yes 
No 
Nurse letter note on 
EDS 
Has a ‘discharge letter note’ been entered on EDS by nurse? 
Medicines-related 
information in the 
EDS 
   
Allergies Yes 
No 
Allergies section of 
EDS 
Has allergies data been entered in allergies section? 
Discharge 
medications 
Yes 
No 
‘Discharge 
medication’ section 
of EDS 
Has a complete and accurate list of medicines been entered in 
‘discharge medication’ section? 
Number of TTA 
items prescribed 
Whole number 
(commencing at 1) 
‘Discharge 
medication’ section 
of EDS 
Count individual TTA items in the ‘discharge medication’ 
section of EDS. Include each drug only once if loading regime, 
reducing regime or duplicate prescribed 
Inpatient medication 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about inpatient medication been entered in the 
‘discharge letter note’? e.g. IV antibiotics given as inpatient 
 
 XXXI 
Medication changes 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication changes been entered in the 
‘discharge letter note’? Identify if drug or class of drug 
documented as being started, stopped or changed, either 
explicitly, or implied by description of treatment given for a 
specified condition e.g. complete course of antibiotics for 
cellulitis 
Medication 
recommendations 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication recommendations been 
entered in the ‘discharge letter note’? e.g. consider starting drug 
X if symptoms recur 
Information about 
medication 
changes 
   
Admission 
medications stopped 
or changed 
Yes 
No 
‘Discharge 
medication’ list on 
EDS 
Admission 
medication on ‘drug 
history note’ on 
JAC EPMA 
Have admission medications been stopped or changed? 
Compare ‘discharge medication’ list on EDS with admission 
medication list on ‘drug history note’ on JAC EPMA. 
Yes = one or more changes 
No = no changes, DH matches TTA (excluding new 
medications) 
Admission 
medication changes 
listed 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have admission medication changes been listed in ‘discharge 
letter note’?  
Yes = all medications stopped or changed listed 
No = no medications stopped or changed listed 
Incomplete = some medications stopped or changed listed 
N/A = no admission medications stopped or changed 
Reason for 
admission 
medication changes 
stated 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have reasons for admission medication changes been stated in 
‘discharge letter note’? 
Yes = reasons for all medications stopped or changed stated 
No = no reasons for medications stopped or changed stated 
Incomplete = some reasons for medications stopped or changed 
stated 
 XXXII 
N/A = no admission medications stopped or changed 
 
New medications 
started 
Yes 
No 
‘Discharge 
medication’ list on 
EDS 
Admission 
medication on ‘drug 
history note’ on 
JAC EPMA 
 
Have new medication been started? Identify if new medications 
appear on ‘discharge medication’ list on EDS that are not on 
admission medication list on ‘drug history note’ on JAC EPMA 
Yes = new medication on TTA, not on DH 
No = no new medications, TTA matches DH (excluding 
admission medication changes) 
Medication 
additions listed 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have medication additions been listed in ‘discharge letter 
notes’? 
Yes = all new medications listed 
No = no new medications listed 
Incomplete = some new medications listed 
N/A = no new medications started 
 
Reason for 
medication 
additions stated 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have reasons for medication additions been stated in ‘discharge 
letter note’? 
Yes = reasons for all new medications stated 
No = no reasons for new medications stated 
Incomplete = some reasons for new medications stated 
N/A = no new medications started 
 
Medication changes 
note complete and 
accurate 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have all medication changes been listed and reasons stated 
completely and accurately in ‘discharge letter note’? 
Yes = reasons for all medications changes stated 
No = no reasons for medications changes stated 
Incomplete = some reasons for medications changes stated 
N/A = no medication changes 
 
 XXXIII 
Inter-coder 
reliability 
   
Medication changes 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication changes been entered in the 
‘discharge letter note’? Coded by second coder. Identify if drug 
or class of drug documented as being started, stopped or 
changed, either explicitly, or implied by description of treatment 
given for a specified condition e.g. complete course of 
antibiotics for cellulitis 
 
 XXXIV 
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 XXXV 
Standardised document abstraction form for EDS – version 2 
 
 
Category 
 
Data Source of data Coding instructions 
General 
information 
   
Date dispensing list 
retrieved 
DD/MM/YY Dispensing list 
print-out 
Enter date from dispensing list print-out 
Date of admission DD/MM/YY Date of admission 
on JAC EPMA 
Enter date of admission as it appears on JAC EPMA 
Date of discharge DD/MM/YY Date of discharge on 
JAC EPMA 
Enter date of discharge as it appears on JAC EPMA after the 
episode of care is closed when patient discharged 
Day of discharge Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
Date of discharge Code day of week from date of discharge entered 
Month of discharge July 
August 
Date of discharge Code month of discharge from date of discharge entered 
Length of stay Whole number 
(commencing at 1) 
Date of admission 
Date of discharge 
Calculate length of stay by counting the number of days 
between date of admission and date of discharge, each day or 
part day is counted as one day 
Ward F1 
M1 
M2 
M3 
M4 
Ward name on JAC 
EPMA 
After the episode of care has been closed when patient 
discharged, identify ward that issued EDS as it appears on JAC 
EPMA. Code as listed in Table 2.1. 
 XXXVI 
M5 
M6 
M7 
S1 
S2 
S3 
S4 
Division by ward M&E 
S&A 
FS 
Ward code Code division from ward code entered, as categorised in Table 
2.1. 
Drug history note 
recorded 
Yes 
No 
‘Drug history note’ 
recorded on JAC 
EPMA 
Has a ‘drug history note’ been recorded on JAC? After the 
episode of care has been closed when patient discharged, check 
if a ‘drug history note’ was recorded on JAC EPMA 
Unique 
identification 
number 
e.g. S1/001 Ward code and 
‘Yes’ in drug 
history note 
recorded 
When EDS meets all inclusion criteria allocate a unique 
identification number comprising ward code/three digit number 
commencing at 001 and allocated sequentially by date of 
discharge 
Preparation of the 
EDS 
   
Division by 
consultant 
M&E 
S&A 
FS 
Consultant name on 
EDS 
Code division from consultant name on EDS, as categorised in 
the published bleep list 
Doctor preparing 
the EDS 
F1M&E 
F2M&E 
RegistrarM&E 
ConsultantM&E 
F1S&A 
F2S&A 
RegistrarS&A 
ConsultantS&A 
F2FS 
Doctor name on 
EDS 
Code name of doctor preparing EDS by grade and division, 
using the published bleep list for the period during which the 
EDS was prepared e.g. F1S&A – foundation year 1 doctor 
working in S&A division 
 XXXVII 
RegistrarFS 
ConsultantFS 
Letter status ‘Complete’ 
Revised 
Not printed 
Delayed print 
Provisional 
Letter status on EDS Code from print record on footer of EDS as follows: 
‘Complete’ = date ‘originally printed’ during episode of care 
Revised = date ‘revised’ during episode of care 
Not printed = not ‘originally printed’ prior to date of coding 
Delayed print = date ‘originally printed’ is after discharge date 
Provisional = no ‘originally printed’ date, ‘PROVISIONAL’ on 
header of EDS 
 
Date EDS 
printed/revised 
DD/MM/YY Date originally 
printed/revised on 
EDS 
Enter date ‘originally printed’ or ‘revised’ from print record on 
footer of EDS. If ‘originally printed’ date and ‘revised’ date 
occur together enter ‘revised’ date 
 
Preparation of EDS 
prior to discharge 
Day of discharge 
Day before 
discharge 
Two days before 
discharge 
Three or more days 
before discharge 
Date EDS originally 
printed/revised 
Date of discharge 
Code by comparing the date originally printed/revised with the 
date of discharge 
Doctor letter notes Yes 
No 
Doctor letter note on 
EDS 
 
Has a ‘discharge letter note’ been entered on EDS by doctor? 
Pharmacist letter 
notes 
Yes 
No 
Pharmacist letter 
note on EDS 
 
Has a ‘discharge letter note’ been entered on EDS by 
pharmacist? 
Nurse letter notes Yes 
No 
Nurse letter note on 
EDS 
 
Has a ‘discharge letter note’ been entered on EDS by nurse? 
 XXXVIII 
Medicines-related 
information in the 
EDS 
   
Allergies Absent data 
Drug allergy 
No known drug 
allergies (NKDA) 
Non-drug allergy 
Undetermined  
Allergies section of 
EDS 
Code from data entered in allergies section of EDS as follows: 
Absent = no data entry 
Drug allergy = one or more drug names entered 
NKDA = ‘no known drug allergies’ entered 
Non-drug allergy = one or more non-drug names entered 
Undetermined = ‘allergy status undetermined’ entered 
Discharge 
medications 
Complete 
Incomplete 
Duplicate 
Discrepancy 
‘Discharge 
medication’ section 
of EDS 
Code from ‘discharge medication’ list on EDS as follows: 
Complete = drug, form, dose, route, frequency, days supply and 
GP to continue complete and unambiguous 
Incomplete = one or more incomplete items 
Duplicate = one or more duplicate medications listed 
Discrepancy = one or more discrepancy in medication list e.g. 
ramipril 5mg cap, dose 2.5mg om 
Number of TTA 
items prescribed 
Whole number 
(commencing at 1) 
‘Discharge 
medication’ section 
of EDS 
Count individual TTA items in the discharge medication section 
of EDS. Include each drug only once if loading regime, 
reducing regime or duplicate prescribed 
Inpatient medication 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about inpatient medication been entered in the 
‘discharge letter note’? e.g. IV antibiotics given as inpatient 
Medication changes 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication changes been entered in the 
‘discharge letter note’? Identify if drug or class of drug 
documented as being started, stopped or changed, either 
explicitly, or implied by description of treatment given for a 
specified condition e.g. complete course of antibiotics for 
cellulitis 
Medication 
recommendations 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication recommendations been 
entered in the ‘discharge letter note’? e.g. consider starting drug 
X if symptoms recur 
 XXXIX 
Information about 
medication 
changes 
   
Admission 
medications stopped 
or changed 
Yes 
No 
‘Discharge 
medication’ list on 
EDS 
Admission 
medication on ‘drug 
history note’ on 
JAC EPMA 
Have admission medications been stopped or changed? 
Compare ‘discharge medication’ list on EDS with admission 
medication list on ‘drug history note’ on JAC EPMA. 
Yes = one or more changes 
No = no changes, DH matches TTA (excluding new 
medications) 
Admission 
medication changes 
listed 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have admission medication changes been listed in ‘discharge 
letter note’?  
Yes = all medications stopped or changed listed 
No = no medications stopped or changed listed 
Incomplete = some medications stopped or changed listed 
N/A = no admission medications stopped or changed 
Reason for 
admission 
medication changes 
stated 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have reasons for admission medication changes been stated in 
‘discharge letter note’? 
Yes = reasons for all medications stopped or changed stated 
No = no reasons for medications stopped or changed stated 
Incomplete = some reasons for medications stopped or changed 
stated 
N/A = no admission medications stopped or changed 
New medications 
started 
Yes 
No 
‘Discharge 
medication’ list on 
EDS 
Admission 
medication on ‘drug 
history note’ on 
JAC EPMA 
 
Have new medication been started? Identify if new medications 
appear on ‘discharge medication’ list on EDS that are not on 
admission medication list on ‘drug history note’ on JAC EPMA 
Yes = new medication on TTA, not on DH 
No = no new medications, TTA matches DH (excluding 
admission medication changes) 
 XL 
Medication 
additions listed 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have medication additions been listed in ‘discharge letter 
notes’? 
Yes = all new medications listed 
No = no new medications listed 
Incomplete = some new medications listed 
N/A = no new medications started 
Reason for 
medication 
additions stated 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have reasons for medication additions been stated in ‘discharge 
letter note’? 
Yes = reasons for all new medications stated 
No = no reasons for new medications stated 
Incomplete = some reasons for new medications stated 
N/A = no new medications started 
Medication changes 
note complete and 
accurate 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have all medication changes been listed and reasons stated 
completely and accurately in ‘discharge letter note’? 
Yes = reasons for all medications changes stated 
No = no reasons for medications changes stated 
Incomplete = some reasons for medications changes stated 
N/A = no medication changes 
Inter-coder 
reliability 
   
Medication changes 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication changes been entered in the 
‘discharge letter note’? Coded by second coder. Identify if drug 
or class of drug documented as being started, stopped or 
changed, either explicitly, or implied by description of treatment 
given for a specified condition e.g. complete course of 
antibiotics for cellulitis 
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Standardised document abstraction form for EDS – version 3 
 
 
Category 
 
Data Source of data Coding instructions 
General 
information 
   
Date dispensing list 
retrieved 
DD/MM/YY Dispensing list 
print-out 
Enter date from dispensing list print-out 
Date of admission DD/MM/YY Date of admission 
on JAC EPMA 
Enter date of admission as it appears on JAC EPMA 
Date of discharge DD/MM/YY Date of discharge on 
JAC EPMA 
Enter date of discharge as it appears on JAC EPMA after the 
episode of care is closed when patient discharged 
Day of discharge Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
Date of discharge Code day of week from date of discharge entered 
Month of discharge July 
August 
Date of discharge Code month of discharge from date of discharge entered 
Length of stay Whole number 
(commencing at 1) 
Date of admission 
Date of discharge 
Calculate length of stay by counting the number of days 
between date of admission and date of discharge, each day or 
part day is counted as one day 
Ward F1 
M1 
M2 
M3 
M4 
Ward name on JAC 
EPMA 
After the episode of care has been closed when patient 
discharged, identify ward that issued EDS as it appears on JAC 
EPMA. Code as listed in Table 2.1. 
 XLIII 
M5 
M6 
M7 
M10 
S1 
S2 
S3 
S4 
S6 
Division by ward M&E 
S&A 
FS 
Ward code Code division from ward code entered, as categorised in Table 
2.1. 
Drug history note 
recorded 
Yes 
No 
‘Drug history note’ 
recorded on JAC 
EPMA 
Has a ‘drug history note’ been recorded on JAC? After the 
episode of care has been closed when patient discharged, check 
if a ‘drug history note’ was recorded on JAC EPMA 
Unique 
identification 
number 
e.g. S1/001 Ward code and 
‘Yes’ in drug 
history note 
recorded 
When EDS meets all inclusion criteria allocate a unique 
identification number comprising ward code/three digit number 
commencing at 001 and allocated sequentially by date of 
discharge 
Preparation of the 
EDS 
   
Division by 
consultant 
M&E 
S&A 
FS 
Consultant name on 
EDS 
Code division from consultant name on EDS, as categorised in 
the published bleep list 
Doctor preparing 
the EDS 
F1M&E 
F2M&E 
RegistrarM&E 
ConsultantM&E 
F1S&A 
F2S&A 
RegistrarS&A 
Doctor name on 
EDS 
Code name of doctor preparing EDS by grade and division, 
using the published bleep list for the period during which the 
EDS was prepared e.g. F1S&A – foundation year 1 doctor 
working in S&A division 
 XLIV 
ConsultantS&A 
F2FS 
RegistrarFS 
ConsultantFS 
Letter status ‘Complete’ 
Revised 
Not printed 
Delayed print 
Provisional 
Letter status on EDS Code from print record on footer of EDS as follows: 
‘Complete’ = date ‘originally printed’ during episode of care 
Revised = date ‘revised’ during episode of care 
Not printed = not ‘originally printed’ prior to date of coding 
Delayed print = date ‘originally printed’ is after discharge date 
Provisional = no ‘originally printed’ date, ‘PROVISIONAL’ on 
header of EDS 
Date EDS 
printed/revised 
DD/MM/YY Date originally 
printed/revised on 
EDS 
Enter date ‘originally printed’ or ‘revised’ from print record on 
footer of EDS. If ‘originally printed’ date and ‘revised’ date 
occur together enter ‘revised’ date 
Preparation of EDS 
prior to discharge 
Day of discharge 
Day before 
discharge 
Two days before 
discharge 
Three or more days 
before discharge 
Date EDS originally 
printed/revised 
Date of discharge 
Code by comparing the date originally printed/revised with the 
date of discharge 
Doctor letter notes Yes 
No 
Doctor letter note on 
EDS 
 
Has a ‘discharge letter note’ been entered on EDS by doctor? 
Pharmacist letter 
notes 
Yes 
No 
Pharmacist letter 
note on EDS 
 
Has a ‘discharge letter note’ been entered on EDS by 
pharmacist? 
Nurse letter notes Yes 
No 
Nurse letter note on 
EDS 
 
Has a ‘discharge letter note’ been entered on EDS by nurse? 
 XLV 
Medicines-related 
information in the 
EDS 
   
Allergies Absent data 
Drug allergy 
No known drug 
allergies (NKDA) 
Non-drug allergy 
Undetermined  
Allergies section of 
EDS 
Code from data entered in allergies section of EDS as follows: 
Absent = no data entry 
Drug allergy = one or more drug names entered 
NKDA = ‘no known drug allergies’ entered 
Non-drug allergy = one or more non-drug names entered 
Undetermined = ‘allergy status undetermined’ entered 
Discharge 
medications 
Complete 
Incomplete 
Duplicate 
Discrepancy 
‘Discharge 
medication’ section 
of EDS 
Code from ‘discharge medication’ list on EDS as follows: 
Complete = drug, form, dose, route, frequency, days supply and 
GP to continue complete and unambiguous 
Incomplete = one or more incomplete items 
Duplicate = one or more duplicate medications listed 
Discrepancy = one or more discrepancy in medication list e.g. 
ramipril 5mg cap, dose 2.5mg om 
Number of TTA 
items prescribed 
Whole number 
(commencing at 1) 
‘Discharge 
medication’ section 
of EDS 
Count individual TTA items in the ‘discharge medication’ 
section of EDS. Include each drug only once if loading regime, 
reducing regime or duplicate prescribed 
Inpatient medication 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about inpatient medication been entered in the 
‘discharge letter note’? e.g. IV antibiotics given as inpatient 
Medication changes 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication changes been entered in the 
‘discharge letter note’? Identify if drug or class of drug 
documented as being started, stopped or changed, either 
explicitly, or implied by description of treatment given for a 
specified condition e.g. complete course of antibiotics for 
cellulitis 
Medication 
recommendations 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication recommendations been 
entered in the ‘discharge letter note’? e.g. consider starting drug 
X if symptoms recur 
 XLVI 
Drugs modified note Yes 
No 
N/A 
‘Drugs modified 
note’ on EDS 
Has a ‘drugs modified note’ been entered on EDS? 
Yes = note entered 
No = no note 
N/A = EDS printed prior to 24 July JAC upgrade 
Note to appear in 
EDS 
Yes 
No 
N/A 
‘Note to appear in 
EDS’ on EDS 
Has a ‘note to appear in EDS’ been entered on EDS? 
Yes = note entered 
No = no note 
N/A = EDS printed prior to 24 July JAC upgrade 
Information about 
medication 
changes 
   
Admission 
medications stopped 
or changed 
Yes 
No 
‘Discharge 
medication’ list on 
EDS 
Admission 
medication on ‘drug 
history note’ on 
JAC EPMA 
Have admission medications been stopped or changed? 
Compare ‘discharge medication’ list on EDS with admission 
medication list on ‘drug history note’ on JAC EPMA. 
Yes = one or more changes 
No = no changes, DH matches TTA (excluding new 
medications) 
Admission 
medication changes 
listed 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have admission medication changes been listed in ‘discharge 
letter note’?  
Yes = all medications stopped or changed listed 
No = no medications stopped or changed listed 
Incomplete = some medications stopped or changed listed 
N/A = no admission medications stopped or changed 
Reason for 
admission 
medication changes 
stated 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have reasons for admission medication changes been stated in 
‘discharge letter note’? 
Yes = reasons for all medications stopped or changed stated 
No = no reasons for medications stopped or changed stated 
Incomplete = some reasons for medications stopped or changed 
stated 
N/A = no admission medications stopped or changed 
 XLVII 
New medications 
started 
Yes 
No 
‘Discharge 
medication’ list on 
EDS 
Admission 
medication on ‘drug 
history note’ on 
JAC EPMA 
 
Have new medication been started? Identify if new medications 
appear on ‘discharge medication’ list on EDS that are not on 
admission medication list on ‘drug history note’ on JAC EPMA 
Yes = new medication on TTA, not on DH 
No = no new medications, TTA matches DH (excluding 
admission medication changes) 
Medication 
additions listed 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have medication additions been listed in ‘discharge letter 
notes’? 
Yes = all new medications listed 
No = no new medications listed 
Incomplete = some new medications listed 
N/A = no new medications started 
 
Reason for 
medication 
additions stated 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have reasons for medication additions been stated in ‘discharge 
letter note’? 
Yes = reasons for all new medications stated 
No = no reasons for new medications stated 
Incomplete = some reasons for new medications stated 
N/A = no new medications started 
 
Medication changes 
note complete and 
accurate 
Yes 
No 
Incomplete 
N/A 
‘Discharge letter 
note’ on EDS 
Have all medication changes been listed and reasons stated 
completely and accurately in ‘discharge letter note’? 
Yes = reasons for all medications changes stated 
No = no reasons for medications changes stated 
Incomplete = some reasons for medications changes stated 
N/A = no medication changes 
 
 
 
 XLVIII 
Inter-coder 
reliability 
   
Medication changes 
note 
Yes 
No 
‘Discharge letter 
note’ on EDS 
Has information about medication changes been entered in the 
‘discharge letter note’? Coded by second coder. Identify if drug 
or class of drug documented as being started, stopped or 
changed, either explicitly, or implied by description of treatment 
given for a specified condition e.g. complete course of 
antibiotics for cellulitis 
 
 
 
